Generic Name,Drug Class,Indications,Dosage Form,Strength,Route of Administration,Side Effects,Contraindications,Interaction warnings & Precautions,Storage Conditions,Pregnancy Category,Reference,Availability
Acyclovir,Antiviral,Herpes simplex virus (HSV) infections,Tablet,400 mg,Oral,Varicella zoster virus (VZV) infections,Nausea ,Probenecid may decrease acyclovir clearance increasing its levels Maintain adequate hydration to prevent nephrotoxicity especially in elderly or dehydrated patients.,Room Temperature,Human studies have proved safety,"Lexicomp, Micromedex",Prescription
Adalimumab,TNF Blocker,Autoimmune disorders (RA,Solution,40 mg/0.8 mL,Subcutaneous,Crohn's,psoriasis,Live vaccines should not be given concurrently due to increased risk of infection Serious infections including tuberculosis and invasive fungal infections may occur.,Refrigerate Do Not Freeze Protect from light,Animal studies have demonstrated safety,"FDA Prescribing Information, Briggs",Prescription
Adapalene,Retinoid,Acne vulgaris,Gel,0.10%,Topical,Skin dryness,erythema,No major systemic drug interactions due to minimal absorption Use of abrasive soaps or cosmetics may cause significant irritation Avoid excessive sun exposure.,Room Temperature,Contraindicated (not allowed),"FDA Prescribing Information, Avoid topical use on large areas",No prescription required
Albendazole,Anthelmintic,Parasitic worm infections,Tablet,200 mg,Oral,Abdominal pain,nausea,Cimetidine praziquantel and dexamethasone can increase albandinazole sulfoxide levels Bone marrow suppression is rare but possible monitor blood counts.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Albuterol-Ipratropium,SABA + Anticholinergic,COPD,Solution for Nebulization,3 mL/3 mL (0.5/2.5),Inhalation,bronchospasm,Cough,Beta-blockers may antagonize the effects of albuterol Use cautiously with other anticholinergic drugs to avoid additive effects Paradoxical bronchospasm may occur use a different medication if it happens.,Room Temperature,Animal studies have demonstrated safety,"Lexicomp, Micromedex",Prescription
Alendronate,Bisphosphonate,Osteoporosis,Tablet,70 mg,Oral,osteoporosis prevention,Esophageal irritation,Calcium supplements antacids and other oral medications can interfere with absorption administer at least 30 minutes before any other oral product Risk of esophageal irritation and osteonecrosis of the jaw.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Allopurinol,Xanthine Oxidase Inhibitor,Gout,Tablet,300 mg,Oral,hyperuricemia,Rash,Increases concentrations of azathioprine and mercaptopurine may increase risk of rash with ampicillin and amoxicillin Severe skin reactions like Stevens-Johnson syndrome can occur discontinue at first sign of rash.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,"Lexicomp, Micromedex",Prescription
Alprazolam,Benzodiazepine,Anxiety disorders,Tablet,0.5 mg,Oral,panic disorder,Sedation,Strong CYP3A4 inhibitors like ketoconazole can significantly increase levels Risk of profound sedation respiratory depression and coma if used with opioids or alcohol Abrupt discontinuation can cause seizures.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Amantadine,Antiviral / Antiparkinsonian,Parkinson's disease,Capsule,100 mg,Oral,influenza A,Dizziness,Anticholinergic drugs may have additive side effects Use cautiously in patients with seizure history or psychiatric disorders livedo reticularis and ankle edema are common.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Amikacin,Aminoglycoside Antibiotic,Serious bacterial infections,Solution,500 mg/2 mL,Intravenous,Nephrotoxicity,ototoxicity,Other nephrotoxic or ototoxic drugs like vancomycin or furosemide increase risk of toxicity Monitor peak and trough levels to minimize risk of nephrotoxicity and ototoxicity.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Aminoglycoside risk of ototoxicity),Prescription
Amitriptyline,Tricyclic Antidepressant,Depression,Tablet,25 mg,Oral,neuropathic pain,Sedation,MAOIs can cause serotonin syndrome and hyperpyrexia Strong anticholinergic effects may occur with other drugs like benztropine Increased risk of suicide in children and young adults.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Amlodipine,Dihydropyridine CCB,Hypertension,Tablet,5 mg,Oral,angina,Peripheral edema,Weak CYP3A4 inhibitors may increase levels but no dosage adjustment is typically needed Monitor for hypotension and peripheral edema dose-related side effects.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Amlodipine-Benazepril,CCB + ACE Inhibitor,Hypertension,Capsule,5/20 mg,Oral,Peripheral edema,cough,NSAIDs may reduce the antihypertensive effect Lithium levels may increase Risk of angioedema can occur at any time discontinue immediately if it occurs.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information (ACE Inhibitor risk),Prescription
Amlodipine-Valsartan,CCB + ARB,Hypertension,Tablet,5/160 mg,Oral,Peripheral edema,dizziness,NSAIDs may reduce the antihypertensive effect Lithium levels may increase Use in pregnancy can cause injury and death to the developing fetus.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information (ARB risk),Prescription
Amoxicillin,Penicillin Antibiotic,Bacterial infections,Capsule,500 mg,Oral,Diarrhea,nausea,Probenecid decreases renal tubular secretion of amoxicillin May reduce efficacy of oral contraceptives Serious and occasionally fatal hypersensitivity reactions have been reported.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Amoxicillin-Clavulanate,Penicillin Antibiotic + Beta-Lactamase Inhibitor,Bacterial infections,Tablet,875/125 mg,Oral,Diarrhea,nausea,Probenecid decreases renal tubular secretion Disulfiram-like reactions have been reported with alcohol Cholestatic jaundice may occur and is usually reversible.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Amphetamine,CNS Stimulant,ADHD,Tablet,10 mg,Oral,narcolepsy,Insomnia,MAOIs can cause hypertensive crisis Alkalinizing agents increase urinary excretion and acidifying agents decrease it High potential for abuse and dependence.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Ampicillin,Penicillin Antibiotic,Bacterial infections,Capsule,500 mg,Oral,Diarrhea,rash,Probenecid decreases renal tubular secretion of ampicillin Allopurinol may increase the incidence of skin rashes Serious and occasionally fatal hypersensitivity reactions have been reported.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Ampicillin-Sulbactam,Penicillin Antibiotic + Beta-Lactamase Inhibitor,Bacterial infections,Powder for Injection,3 g (2/1 g),Intravenous,Diarrhea,rash,Probenecid decreases renal tubular secretion Disulfiram-like reactions have been reported with alcohol Serious and occasionally fatal hypersensitivity reactions have been reported.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Anastrozole,Aromatase Inhibitor,Breast cancer (hormone receptor-positive),Tablet,1 mg,Oral,Hot flashes,arthralgia,Tamoxifen may reduce anastrozole levels Estrogen-containing medications should not be used Decreases bone mineral density increasing fracture risk.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Apixaban,Direct Oral Anticoagulant (Factor Xa Inhibitor),Stroke prevention in atrial fibrillation,Tablet,5 mg,Oral,VTE treatment,Bleeding,Strong dual inducers of CYP3A4 and P-gp (eg rifampin) decrease apixaban levels increasing stroke risk Risk of serious and fatal bleeding discontinue if active bleeding occurs.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information (Risk of hemorrhage),Prescription
Apremilast,PDE4 Inhibitor,Psoriasis,Tablet,30 mg,Oral,psoriatic arthritis,Diarrhea,Strong CYP450 inducers (eg rifampin) reduce apremilast exposure May cause weight loss and depression monitor patient accordingly.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Aripiprazole,Atypical Antipsychotic,Schizophrenia,Tablet,5 mg,Oral,bipolar disorder,manic/mixed episodes,Strong CYP3A4 inhibitors (eg ketoconazole) or inducers (eg carbamazepine) require dose adjustment May cause suicidal thoughts and metabolic changes including weight gain and dyslipidemia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Armodafinil,CNS Stimulant,Narcolepsy,Tablet,150 mg,Oral,sleep apnea,shift work disorder,Can reduce efficacy of cyclosporine and hormonal contraceptives Strong CYP3A4 inducers or inhibitors may affect levels Serious skin reactions including Stevens-Johnson syndrome have been reported.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Asenapine,Atypical Antipsychotic,Schizophrenia,Tablet,5 mg,Sublingual,bipolar disorder,Somnolence,Strong CYP1A2 inhibitors like fluvoxamine increase asenapine levels Sublingual administration food and drink can decrease absorption May cause cerebrovascular events in elderly patients with dementia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Aspirin,NSAID / Antiplatelet,Pain,Tablet,81 mg,Oral,fever,inflammation,Anticoagulants like warfarin increase bleeding risk Concomitant use with other NSAIDs increases GI toxicity Risk of Reye's syndrome in children and teenagers with viral infections.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Risk of closure of ductus arteriosus),No prescription required
Atenolol,Beta-Blocker,Hypertension,Tablet,25 mg,Oral,angina,tachycardia,Calcium channel blockers like verapamil may cause bradycardia and heart failure Abrupt withdrawal may exacerbate angina pectoris or cause myocardial infarction.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information (Beta-blocker risk of fetal bradycardia),Prescription
Atovaquone,Antiprotozoal,Pneumocystis jirovecii pneumonia (PCP) prophylaxis and treatment,Suspension,750 mg,Oral,Rash,nausea,Metoclopramide and rifampin reduce plasma concentrations Should not be used for serious Pneumocystis pneumonia (PCP) in patients who cannot take it with food.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Atovaquone-Proguanil,Antimalarial,Malaria prevention and treatment,Tablet,250/100 mg,Oral,Headache,abdominal pain,Metoclopramide and rifampin reduce atovaquone concentrations Not for severe malaria or prophylaxis in patients with severe renal impairment.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Azathioprine,Immunosuppressant,Rheumatoid arthritis,Tablet,50 mg,Oral,immunosuppression in transplants,Myelosuppression,Allopurinol inhibits xanthine oxidase increasing levels of active metabolites leading to severe myelosuppression Myelosuppression is dose-related and requires frequent CBC monitoring.,Refrigerate,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Azelaic Acid,Topical Antiacne,Rosacea,Gel,15%,Topical,acne vulgaris,Skin burning,No significant drug interactions Avoid contact with eyes and mucous membranes May cause hypopigmentation in patients with dark complexions.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Azithromycin,Macrolide Antibiotic,Bacterial infections,Tablet,250 mg,Oral,Diarrhea,nausea,Nelfinavir increases azithromycin levels May potentiate the effects of warfarin and digoxin May cause QT prolongation and subsequent arrhythmias.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Bacitracin,Polypeptide Antibiotic,Topical skin infections,Ointment,500 unit/g,Topical,Hypersensitivity reactions,Hypersensitivity,No significant systemic drug interactions due to minimal absorption For topical use only not for eyes or deep wounds.,Room Temperature,Animal studies have demonstrated safety,"Lexicomp, Micromedex",No prescription required
Bacitracin-Polymyxin,Antibiotic Combination,Topical skin infections,Ointment,5000-10000 unit/g,Topical,Hypersensitivity reactions,Hypersensitivity to components,No significant systemic drug interactions due to minimal absorption For topical use only not for eyes or deep wounds.,Room Temperature,Animal studies have demonstrated safety,"Lexicomp, Micromedex",No prescription required
Baclofen,Skeletal Muscle Relaxant,Muscle spasticity,Tablet,10 mg,Oral,Sedation,dizziness,CNS depressants like alcohol and opioids can increase sedation Abrupt discontinuation can cause hallucinations and seizures.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Beclomethasone,Inhaled Corticosteroid,Asthma,Inhaler,40 mcg/actuation,Inhalation,COPD,Oral candidiasis,No significant drug interactions Rinse mouth after inhalation to prevent oral candidiasis Adrenal insufficiency may occur when transferring from systemic steroids.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Benazepril,ACE Inhibitor,Hypertension,Tablet,10 mg,Oral,heart failure,Cough,NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Risk of angioedema can occur at any time discontinue immediately.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information (ACE Inhibitor risk),Prescription
Bendamustine,Alkylating Agent,Chronic lymphocytic leukemia (CLL),Solution,25 mg/mL,Intravenous,Myelosuppression,nausea,Inhibitors of CYP1A2 may increase bendamustine exposure Myelosuppression is common monitor blood counts regularly Infusion reactions and skin reactions may occur.,Refrigerate Protect from light,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Benzonatate,Antitussive,Cough suppression,Capsule,100 mg,Oral,Dizziness,drowsiness,No significant drug interactions Do not chew or swallow capsules whole as it can cause local anesthesia of the oral mucosa and choking.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Benztropine,Anticholinergic,Parkinson's disease,Tablet,0.5 mg,Oral,drug-induced extrapyramidal symptoms,Dry mouth,Other anticholinergic drugs can have additive effects Use with caution in hot weather may cause heatstroke May impair mental and physical abilities required for driving.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Betamethasone,Corticosteroid,Inflammatory conditions,Cream,0.10%,Topical,Hyperglycemia,fluid retention,Live vaccines should not be given concurrently Phenytoin phenobarbital and rifampin reduce corticosteroid effects Systemic effects can occur with extensive topical use.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Bethanechol,Cholinergic,Urinary retention,Tablet,10 mg,Oral,Abdominal cramps,salivation,Other cholinergic agents can have additive effects Bethanechol is contraindicated in conditions where increased muscular activity of the GI tract or bladder might be harmful.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Bisoprolol,Beta-Blocker,Hypertension,Tablet,5 mg,Oral,heart failure,Bradycardia,Calcium channel blockers like verapamil may cause bradycardia and heart failure Abrupt withdrawal may exacerbate angina pectoris or cause myocardial infarction.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information (Beta-blocker risk),Prescription
Bisoprolol-Hydrochlorothiazide,Beta-Blocker + Thiazide Diuretic,Hypertension,Tablet,5/6.25 mg,Oral,Bradycardia,dizziness,NSAIDs may diminish the antihypertensive effect Lithium levels may be increased May exacerbate glucose intolerance and hyperlipidemia.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information (ACE Inhibitor/Thiazide risk),Prescription
Bortezomib,Proteasome Inhibitor,Multiple myeloma,Powder for Injection,3.5 mg,Subcutaneous,Peripheral neuropathy,nausea,Strong CYP3A4 inducers may decrease efficacy Peripheral neuropathy is a common and sometimes severe toxicity requiring dose adjustment.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Bosentan,Endothelin Receptor Antagonist,Pulmonary arterial hypertension (PAH),Tablet,62.5 mg,Oral,Headache,nasopharyngitis,Strong CYP3A4 inducers like rifampin decrease levels and inhibitors like ketoconazole increase levels Requires monthly monitoring of liver enzymes due to risk of hepatotoxicity.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Brexpiprazole,Atypical Antipsychotic,Schizophrenia,Tablet,1 mg,Oral,adjunct for depression,Weight gain,Strong CYP3A4 or CYP2D6 inhibitors require dose adjustment May cause suicidal thoughts and metabolic changes including weight gain and dyslipidemia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Brimonidine,Alpha-2 Adrenergic Agonist,Glaucoma,Solution,0.10%,Ophthalmic,ocular hypertension,Ocular allergy,CNS depressants may potentiate effects MAOIs may potentiate vasoconstrictive effect May cause fatigue and drowsiness in some patients.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Brinzolamide,Carbonic Anhydrase Inhibitor,Glaucoma,Suspension,1%,Ophthalmic,ocular hypertension,Blurred vision,Oral carbonic anhydrase inhibitors may have additive effects Salicylates may cause acid-base disturbances Sulfonamide hypersensitivity reactions may occur.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Bromocriptine,Dopamine Agonist,Parkinson's disease,Tablet,2.5 mg,Oral,hyperprolactinemia,Nausea,Other drugs that lower blood pressure may have additive effects Ergot-related drugs may cause fibrosis of cardiac valves with long-term use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Budesonide,Inhaled Corticosteroid,Asthma,Suspension for Nebulization,3 mg/2 mL,Inhalation,COPD,Oral candidiasis,Strong CYP3A4 inhibitors like ketoconazole may increase systemic exposure Rinse mouth after inhalation to prevent oral candidiasis.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Bumetanide,Loop Diuretic,Edema (heart failure,Tablet,1 mg,Oral,hepatic,renal),Other ototoxic drugs may increase risk of hearing loss Indomethacin may reduce the diuretic effect Profound diuresis and electrolyte depletion can occur.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Buprenorphine,Opioid Partial Agonist,Pain management,Tablet,8 mg,Sublingual,opioid use disorder,Constipation,Benzodiazepines and other CNS depressants increase risk of respiratory depression Can precipitate withdrawal in patients dependent on other opioids.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Bupropion,Atypical Antidepressant,Depression,Tablet (SR),150 mg,Oral,smoking cessation,Insomnia,MAOIs can increase risk of hypertensive episodes Lowers seizure threshold in a dose-dependent manner.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Buspirone,Anxiolytic,Generalized anxiety disorder,Tablet,10 mg,Oral,Dizziness,nausea,MAOIs may increase blood pressure Use cautiously with other CNS depressants Not effective for benzodiazepine withdrawal.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Butalbital-Acetaminophen-Caffeine,Barbiturate + Analgesic,Tension headache,Tablet,50/325/40 mg,Oral,Sedation,dizziness,CNS depressants including alcohol can cause additive sedation Barbiturate component induces CYP450 enzymes reducing efficacy of many drugs.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Barbiturate risk),Prescription
Butoconazole,Antifungal,Vaginal yeast infections,Cream,2%,Vaginal,Vaginal burning,itching,No significant drug interactions For vaginal use only not for ophthalmic or oral use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Cabergoline,Dopamine Agonist,Hyperprolactinemia,Tablet,0.5 mg,Oral,Nausea,headache,Other drugs that lower blood pressure may have additive effects Ergot-related drugs may cause fibrosis of cardiac valves with long-term use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Calcipotriene,Vitamin D Analog,Plaque psoriasis,Ointment,0.01%,Topical,Skin irritation,hypercalcemia,No significant drug interactions Topical use only excessive use can lead to hypercalcemia.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Calcitonin,Calcium Regulator,Hypercalcemia,Spray,200 IU/actuation,Nasal,osteoporosis,Nausea,No significant drug interactions Potential for serious allergic reactions including anaphylaxis.,Refrigerate,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Calcitriol,Vitamin D Analog,Hypocalcemia,Capsule,0.25 mcg,Oral,Hypercalcemia,headache,Cholestyramine may impair absorption Magnesium-containing antacids may cause hypermagnesemia Can cause hypercalcemia monitor serum calcium levels.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information (Hypercalcemia risk),Prescription
Calcium Carbonate,Antacid / Calcium Supplement,Antacid,Tablet,500 mg,Oral,calcium supplementation,Constipation,Can decrease absorption of tetracyclines and fluoroquinolones administer separately Excessive use can cause hypercalcemia and milk-alkali syndrome.,Room Temperature,Animal studies have demonstrated safety,Generally considered safe in pregnancy,No prescription required
Canagliflozin,SGLT2 Inhibitor,Type 2 diabetes,Tablet,100 mg,Oral,Genital mycotic infections,UTI,Rifampin decreases canagliflozin levels May increase risk of hypotension with diuretics Can cause genital mycotic infections and volume depletion.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information (Not recommended in 2nd/3rd trim),Prescription
Candesartan,ARB,Hypertension,Tablet,8 mg,Oral,heart failure,Hyperkalemia,NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Use in pregnancy can cause injury and death to the developing fetus.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information (ARB risk),Prescription
Capecitabine,Antimetabolite,Breast cancer,Tablet,500 mg,Oral,colorectal cancer,Diarrhea,Warfarin interaction can lead to serious bleeding and death Patients with DPD deficiency are at risk for severe toxicity.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Captopril,ACE Inhibitor,Hypertension,Tablet,25 mg,Oral,heart failure,Cough,NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Risk of neutropenia and agranulocytosis particularly in renal impairment.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information (ACE Inhibitor risk),Prescription
Carbamazepine,Anticonvulsant,Seizures,Tablet,200 mg,Oral,trigeminal neuralgia,Dizziness,Induces CYP450 enzymes reducing levels of many drugs (eg oral contraceptives warfarin) HLA-B*1502 allele increases risk of serious skin reactions in certain populations.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Neural tube defect risk),Prescription
Carbidopa,Decarboxylase Inhibitor,Parkinson's disease,Tablet,25 mg,Oral,Nausea,dizziness,Nonselective MAOIs are contraindicated When given without levodopa it has no therapeutic effect.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Carboplatin,Alkylating Agent,Ovarian cancer,Solution,10 mg/mL,Intravenous,other cancers,Myelosuppression,Nephrotoxic drugs may enhance platinum-induced renal toxicity Myelosuppression is dose-related and is the dose-limiting toxicity.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Carisoprodol,Skeletal Muscle Relaxant,Muscle pain,Tablet,350 mg,Oral,spasms,Drowsiness,CNS depressants including alcohol can cause additive sedation Metabolism produces meprobamate a controlled substance with abuse potential.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Carvedilol,Alpha/Beta-Blocker,Hypertension,Tablet,12.5 mg,Oral,heart failure,Bradycardia,Other drugs that lower heart rate or blood pressure can have additive effects Abrupt withdrawal may exacerbate angina pectoris or cause myocardial infarction.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information (Beta-blocker risk),Prescription
Caspofungin,Echinocandin Antifungal,Invasive fungal infections,Powder for Injection,70 mg,Intravenous,Fever,phlebitis,Cyclosporine increases caspofungin exposure and may cause elevated liver enzymes Not for use in hepatic impairment.,Refrigerate,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Cefaclor,Cephalosporin Antibiotic,Bacterial infections,Capsule,500 mg,Oral,Diarrhea,nausea,Probenecid may decrease cephalosporin excretion Nephrotoxicity may occur with concurrent use of potent diuretics.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Cefadroxil,Cephalosporin Antibiotic,Bacterial infections,Capsule,500 mg,Oral,Diarrhea,nausea,Probenecid may decrease cephalosporin excretion Nephrotoxicity may occur with concurrent use of potent diuretics.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Cefazolin,Cephalosporin Antibiotic,Bacterial infections,Powder for Injection,1 g,Intravenous,Diarrhea,rash,Probenecid may decrease cephalosporin excretion Nephrotoxicity may occur with concurrent use of potent diuretics.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Cefdinir,Cephalosporin Antibiotic,Bacterial infections,Capsule,300 mg,Oral,Diarrhea,nausea,Antacids and iron supplements decrease absorption May cause red stools due to interaction with iron.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Cefditoren,Cephalosporin Antibiotic,Bacterial infections,Tablet,400 mg,Oral,Diarrhea,nausea,Probenecid may decrease excretion Contraindicated in patients with carnitine deficiency or milk protein allergy.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Cefepime,Cephalosporin Antibiotic,Bacterial infections,Powder for Injection,1 g,Intravenous,Diarrhea,rash,Nephrotoxic drugs may increase the risk of kidney damage May cause neurotoxicity including encephalopathy and nonconvulsive status epilepticus especially in renal impairment.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Cefixime,Cephalosporin Antibiotic,Bacterial infections,Tablet,400 mg,Oral,Diarrhea,nausea,Probenecid may decrease cephalosporin excretion May cause diarrhea including Clostridium difficile-associated diarrhea.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Cefotaxime,Cephalosporin Antibiotic,Bacterial infections,Powder for Injection,1 g,Intravenous,Diarrhea,rash,Probenecid may decrease cephalosporin excretion May cause diarrhea including Clostridium difficile-associated diarrhea.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Cefoxitin,Cephalosporin Antibiotic,Bacterial infections,Powder for Injection,2 g,Intravenous,Diarrhea,nausea,Probenecid may decrease cephalosporin excretion May cause diarrhea including Clostridium difficile-associated diarrhea.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Cefpodoxime,Cephalosporin Antibiotic,Bacterial infections,Tablet,200 mg,Oral,Diarrhea,nausea,Antacids and H2 blockers decrease absorption May cause diarrhea including Clostridium difficile-associated diarrhea.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Cefprozil,Cephalosporin Antibiotic,Bacterial infections,Tablet,500 mg,Oral,Diarrhea,nausea,Probenecid may decrease cephalosporin excretion May cause diarrhea including Clostridium difficile-associated diarrhea.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Ceftaroline,Cephalosporin Antibiotic,Bacterial infections,Powder for Injection,600 mg,Intravenous,Diarrhea,nausea,Drugs that prolong the QT interval may have additive effects May cause diarrhea including Clostridium difficile-associated diarrhea.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Ceftazidime,Cephalosporin Antibiotic,Bacterial infections,Powder for Injection,2 g,Intravenous,Diarrhea,nausea,Probenecid may decrease cephalosporin excretion May cause diarrhea including Clostridium difficile-associated diarrhea.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Ceftibuten,Cephalosporin Antibiotic,Bacterial infections,Capsule,400 mg,Oral,Diarrhea,nausea,Probenecid may decrease cephalosporin excretion May cause diarrhea including Clostridium difficile-associated diarrhea.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Cefuroxime,Cephalosporin Antibiotic,Bacterial infections,Tablet,500 mg,Oral,Diarrhea,nausea,Probenecid may decrease cephalosporin excretion May cause diarrhea including Clostridium difficile-associated diarrhea.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Celecoxib,COX-2 Inhibitor,Osteoarthritis,Capsule,200 mg,Oral,rheumatoid arthritis,pain,ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events including MI and stroke.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (NSAID risk),Prescription
Cephalexin,Cephalosporin Antibiotic,Bacterial infections,Capsule,500 mg,Oral,Diarrhea,nausea,Probenecid may decrease cephalosporin excretion May cause diarrhea including Clostridium difficile-associated diarrhea.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Cetirizine,Antihistamine,Allergic rhinitis,Tablet,10 mg,Oral,urticaria,Somnolence,No significant drug interactions at recommended doses May cause somnolence although less than first-generation antihistamines.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Chloramphenicol,Antibiotic,Serious infections (e.g.,Ointment,0.50%,Ophthalmic,meningitis,typhoid fever),Potentiates effects of warfarin phenytoin and sulfonylureas by inhibiting their metabolism Associated with serious and fatal blood dyscrasias like aplastic anemia.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Gray baby syndrome risk),Prescription
Chlordiazepoxide,Benzodiazepine,Anxiety disorders,Capsule,10 mg,Oral,alcohol withdrawal,Sedation,CNS depressants including alcohol and opioids increase sedation risk Abrupt discontinuation can cause withdrawal symptoms.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Chlorthalidone,Thiazide Diuretic,Hypertension,Tablet,25 mg,Oral,edema,Hypokalemia,Other antihypertensive drugs can have additive effects Lithium levels may be increased Can cause hypokalemia and hyponatremia.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information (Thiazide risk),Prescription
Cholecalciferol,Vitamin D Supplement,Vitamin D deficiency,Softgel,2000 IU,Oral,Hypercalcemia,Hypercalcemia,Cholestyramine and mineral oil may reduce absorption Excessive intake can lead to hypercalcemia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information (Hypercalcemia risk),No prescription required
Ciclopirox,Antifungal,Fungal skin infections,Gel,0.77%,Topical,nail infections,Skin irritation,No significant drug interactions For topical use only not for ophthalmic use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Cidofovir,Antiviral,Cytomegalovirus (CMV) retinitis,Solution,375 mg/5 mL,Intravenous,Nephrotoxicity,neutropenia,Probenecid is required during administration to reduce nephrotoxicity and other nephrotoxic drugs should be avoided Causes severe nephrotoxicity requires pre-hydration and renal function monitoring.,Refrigerate,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Cilostazol,Phosphodiesterase Inhibitor,Intermittent claudication,Tablet,100 mg,Oral,Headache,diarrhea,Strong CYP3A4 or CYP2C19 inhibitors (eg omeprazole) may increase levels Contraindicated in patients with heart failure of any severity.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Cimetidine,H2 Blocker,Peptic ulcer disease,Tablet,400 mg,Oral,GERD,Headache,Inhibits CYP450 enzymes increasing levels of many drugs (eg warfarin phenytoin) Mental confusion and dizziness are more common in elderly or severely ill patients.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required/Prescription
Cinacalcet,Calcimimetic,Hyperparathyroidism,Tablet,30 mg,Oral,Nausea,vomiting,Strong CYP3A4 inhibitors may increase levels Can cause hypocalcemia monitor serum calcium levels closely.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Ciprofloxacin,Fluoroquinolone Antibiotic,Bacterial infections,Tablet,500 mg,Oral,Nausea,diarrhea,Chelates with divalent cations (antacids Ca2+ Fe2+) reducing absorption May enhance effects of warfarin Associated with tendonitis and tendon rupture.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information (Arthropathy risk in animals),Prescription
Cisplatin,Alkylating Agent,Various cancers,Solution,1 mg/mL,Intravenous,Nephrotoxicity,nausea,Nephrotoxic drugs enhance cisplatin-induced kidney damage Ototoxicity is cumulative and may be severe and irreversible.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Citalopram,SSRI,Depression,Tablet,20 mg,Oral,Nausea,somnolence,MAOIs can cause serotonin syndrome and other SSRIs may have additive effects Causes dose-dependent QT prolongation.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Clarithromycin,Macrolide Antibiotic,Bacterial infections,Tablet,500 mg,Oral,Diarrhea,nausea,Inhibits CYP3A4 increasing levels of many drugs (eg statins carbamazepine) May cause QT prolongation and subsequent arrhythmias.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Clindamycin,Lincosamide Antibiotic,Bacterial infections,Capsule,300 mg,Oral,Diarrhea (including C. difficile),nausea,May enhance the effects of neuromuscular blocking agents Causes severe and sometimes fatal Clostridium difficile-associated diarrhea.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Clobetasol,Topical Corticosteroid,Inflammatory skin conditions,Cream,0.05%,Topical,Skin atrophy,burning,No significant drug interactions Systemic absorption can cause reversible HPA axis suppression with potential for glucocorticosteroid insufficiency.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Clomiphene,Selective Estrogen Receptor Modulator (SERM),Ovulation induction,Tablet,50 mg,Oral,Ovarian enlargement,hot flashes,No significant drug interactions May cause visual disturbances and ovarian hyperstimulation syndrome.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Clomipramine,Tricyclic Antidepressant,Obsessive-compulsive disorder (OCD),Capsule,25 mg,Oral,Dry mouth,sedation,MAOIs can cause serotonin syndrome and hyperpyrexia Strong anticholinergic effects may occur with other drugs Increased risk of suicide in children and young adults.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Clonazepam,Benzodiazepine,Seizures,Tablet,1 mg,Oral,panic disorder,Sedation,CNS depressants including alcohol and opioids increase sedation risk Abrupt discontinuation can cause withdrawal seizures.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Clonidine,Alpha-2 Agonist,Hypertension,Tablet,0.1 mg,Oral,ADHD,Dry mouth,CNS depressants may enhance sedative effects Abrupt discontinuation can cause rebound hypertension and nervousness.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Clopidogrel,Antiplatelet,Cardiovascular event prevention,Tablet,75 mg,Oral,Bleeding,rash,Proton pump inhibitors like omeprazole may reduce its antiplatelet effect Risk of bleeding including life-threatening and fatal bleeding.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Clorazepate,Benzodiazepine,Anxiety disorders,Tablet,7.5 mg,Oral,Sedation,dizziness,CNS depressants including alcohol and opioids increase sedation risk Abrupt discontinuation can cause withdrawal symptoms.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Clotrimazole,Antifungal,Fungal skin infections,Cream,1%,Topical,vaginal yeast infections,Skin irritation,No significant drug interactions For topical use only not for ophthalmic use.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,No prescription required
Clozapine,Atypical Antipsychotic,Treatment-resistant schizophrenia,Tablet,100 mg,Oral,Sedation,sialorrhea,Bone marrow suppressants may increase risk of agranulocytosis Can cause severe neutropenia and agranulocytosis requiring mandatory WBC monitoring.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Codeine,Opioid Agonist,Pain,Tablet,30 mg,Oral,cough,Constipation,CNS depressants including alcohol and benzodiazepines increase sedation risk Life-threatening respiratory depression may occur especially in CYP2D6 ultra-rapid metabolizers.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Opioid risk),Prescription
Colchicine,Antigout,Gout flares,Tablet,0.6 mg,Oral,Diarrhea,nausea,Strong CYP3A4 or P-gp inhibitors (eg clarithromycin) dramatically increase levels and risk of fatal toxicity Can cause myelosuppression with chronic use.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Colesevelam,Bile Acid Sequestrant,Hyperlipidemia,Tablet,625 mg,Oral,type 2 diabetes,Constipation,Can decrease the absorption of many other drugs (eg warfarin phenytoin) administer other drugs 4 hours before colesevelam Can cause constipation and may increase triglycerides.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Conjugated Estrogens,Estrogen,Hormone replacement,Tablet,0.625 mg,Oral,osteoporosis prevention,Breast tenderness,Inducers of CYP450 enzymes (eg carbamazepine) may decrease estrogen levels Increases risk of thromboembolic disorders and endometrial cancer.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Cromolyn,Mast Cell Stabilizer,Allergic rhinitis,Spray,5.2 mg/actuation,Nasal,asthma,Throat irritation,No significant drug interactions Not for acute treatment of an asthma attack.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Cyclobenzaprine,Skeletal Muscle Relaxant,Muscle spasms,Tablet,10 mg,Oral,Drowsiness,dry mouth,MAOIs are contraindicated due to risk of serotonin syndrome and hyperpyrexia May impair mental and physical abilities required for driving.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Cyclophosphamide,Alkylating Agent,Various cancers,Tablet,50 mg,Oral,immunosuppression,Myelosuppression,Allopurinol may increase the risk of leukopenia Can cause hemorrhagic cystitis and myelosuppression.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Cyclosporine,Immunosuppressant,Organ transplant rejection,Capsule,100 mg,Oral,autoimmune disorders,Nephrotoxicity,Many drugs can increase levels (eg ketoconazole) or decrease levels (eg rifampin) Nephrotoxicity and hypertension are common dose-related toxicities.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Cyproheptadine,Antihistamine,Allergic reactions,Tablet,4 mg,Oral,appetite stimulation,Sedation,CNS depressants may enhance sedative effects May cause drowsiness and impair mental and physical abilities.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Dabigatran,Direct Thrombin Inhibitor,Stroke prevention in atrial fibrillation,Capsule,150 mg,Oral,VTE treatment,Bleeding,P-gp inducers (eg rifampin) decrease levels and P-gp inhibitors (eg dronedarone) increase levels Risk of serious and sometimes fatal bleeding.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information (Risk of hemorrhage),Prescription
Dabrafenib,Kinase Inhibitor,Melanoma (BRAF V600E mutation),Capsule,75 mg,Oral,Hyperkeratosis,headache,Strong CYP3A4 inducers or inhibitors may alter levels May promote the growth of certain skin cancers monitor for new malignancies.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Dacarbazine,Alkylating Agent,Hodgkin's lymphoma,Powder for Injection,200 mg,Intravenous,melanoma,Nausea,Phenytoin may reduce efficacy Can cause severe nausea and vomiting and myelosuppression.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Dactinomycin,Antitumor Antibiotic,Various cancers,Powder for Injection,0.5 mg,Intravenous,Myelosuppression,nausea,Radiation therapy can recall skin reactions Can cause severe myelosuppression and extravasation injury.,Refrigerate Protect from light,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Dalbavancin,Glycopeptide Antibiotic,Bacterial skin infections,Powder for Injection,500 mg,Intravenous,Nausea,diarrhea,No significant drug interactions Prolonged terminal half-life allows for once-weekly dosing.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Dantrolene,Skeletal Muscle Relaxant,Malignant hyperthermia,Capsule,25 mg,Oral,spasticity,Muscle weakness,CNS depressants and estrogens may enhance hepatotoxicity Can cause hepatotoxicity and muscle weakness.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Dapsone,Antibacterial,Leprosy,Tablet,100 mg,Oral,dermatitis herpetiformis,Hemolytic anemia,Rifampin decreases levels trimethoprim increases levels Can cause hemolytic anemia and methemoglobinemia especially in G6PD deficiency.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Daptomycin,Lipopeptide Antibiotic,Complicated skin infections,Powder for Injection,500 mg,Intravenous,Myopathy,CPK elevation,HMG-CoA reductase inhibitors may increase risk of myopathy May cause myopathy and rhabdomyolysis monitor CPK levels.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Darunavir,Protease Inhibitor,HIV infection,Tablet,600 mg,Oral,Nausea,diarrhea,Strong CYP3A4 inducers (eg rifampin) are contraindicated as they significantly decrease levels May cause severe skin reactions and hepatotoxicity.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Dasatinib,Kinase Inhibitor,Chronic myeloid leukemia (CML),Tablet,100 mg,Oral,Myelosuppression,fluid retention,Antacids and H2 blockers decrease absorption May cause severe myelosuppression and fluid retention.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Daunorubicin,Anthracycline Antibiotic,Leukemias,Powder for Injection,20 mg,Intravenous,Myelosuppression,cardiotoxicity,Other cardiotoxic drugs (eg trastuzumab) increase risk Can cause severe and irreversible cardiotoxicity and myelosuppression.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Deferasirox,Iron Chelator,Iron overload,Tablet,500 mg,Oral,Nausea,vomiting,Avoid concurrent administration with aluminum-containing antacids Can cause renal impairment and hepatic failure monitor function regularly.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Deferoxamine,Iron Chelator,Iron overload,Powder for Injection,500 mg,Subcutaneous,Hypotension,ocular/auditory toxicity,Prochlorperazine may cause loss of consciousness Can cause ocular and auditory toxicity with prolonged use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Delavirdine,NNRTI,HIV infection,Tablet,100 mg,Oral,Rash,headache,Antacids and H2 blockers decrease absorption CYP3A4 inhibitors or inducers will affect levels Rash is a common side effect.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Denosumab,RANK Ligand Inhibitor,Osteoporosis,Solution,60 mg/mL,Subcutaneous,bone metastases,Hypocalcemia,No significant drug interactions Can cause severe hypocalcemia must correct pre-existing hypocalcemia prior to use.,Refrigerate Do Not Freeze Protect from light,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Desipramine,Tricyclic Antidepressant,Depression,Tablet,25 mg,Oral,Dry mouth,sedation,MAOIs can cause serotonin syndrome and hyperpyrexia Strong anticholinergic effects may occur with other drugs Increased risk of suicide in children and young adults.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Desloratadine,Antihistamine,Allergic rhinitis,Tablet,5 mg,Oral,urticaria,Headache,No significant drug interactions at recommended doses Rarely may cause somnolence.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Desmopressin,Vasopressin Analog,Diabetes insipidus,Tablet,0.1 mg,Oral,enuresis,Headache,Other drugs that may increase the risk of water intoxication and hyponatremia Can cause hyponatremia and water intoxication monitor sodium levels.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Desogestrel-Ethinyl Estradiol,Progestin + Estrogen,Contraception,Tablet,0.15/0.03 mg,Oral,Nausea,headache,CYP3A4 inducers (eg rifampin) can decrease efficacy and increase breakthrough bleeding Increases risk of thromboembolic disorders and stroke.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Desonide,Topical Corticosteroid,Inflammatory skin conditions,Ointment,0.05%,Topical,Skin atrophy,burning,No significant drug interactions Systemic absorption can occur with extensive use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Desoximetasone,Topical Corticosteroid,Inflammatory skin conditions,Cream,0.25%,Topical,Skin atrophy,burning,No significant drug interactions Systemic absorption can occur with extensive use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Dexamethasone,Corticosteroid,Inflammatory conditions,Tablet,4 mg,Oral,immunosuppression,Hyperglycemia,CYP3A4 inducers (eg phenytoin) may decrease efficacy and inhibitors may increase effects Can cause hyperglycemia and adrenal suppression with prolonged use.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Dexlansoprazole,Proton Pump Inhibitor,GERD,Capsule (DR),30 mg,Oral,erosive esophagitis,Diarrhea,Can reduce absorption of drugs requiring gastric pH for absorption (eg ketoconazole) May increase risk of Clostridium difficile-associated diarrhea and bone fractures with long-term use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Dexmethylphenidate,CNS Stimulant,ADHD,Tablet,5 mg,Oral,Insomnia,decreased appetite,MAOIs are contraindicated due to risk of hypertensive crisis May exacerbate pre-existing psychosis and cause peripheral vasculopathy.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Dextroamphetamine,CNS Stimulant,ADHD,Tablet,10 mg,Oral,narcolepsy,Insomnia,MAOIs can cause hypertensive crisis Alkalinizing agents increase urinary excretion and acidifying agents decrease it High potential for abuse and dependence.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Diazepam,Benzodiazepine,Anxiety disorders,Tablet,5 mg,Oral,alcohol withdrawal,muscle spasms,CNS depressants including alcohol and opioids increase sedation risk Abrupt discontinuation can cause withdrawal symptoms.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Diclofenac,NSAID,Pain,Tablet,50 mg,Oral,inflammation,osteoarthritis,ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (NSAID risk),Prescription
Dicloxacillin,Penicillin Antibiotic,Bacterial infections,Capsule,500 mg,Oral,Diarrhea,nausea,Probenecid may decrease excretion Serious and occasionally fatal hypersensitivity reactions have been reported.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Dicyclomine,Anticholinergic,Irritable bowel syndrome,Capsule,20 mg,Oral,Dry mouth,dizziness,Other anticholinergic drugs can have additive effects Contraindicated in patients with glaucoma or severe ulcerative colitis.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Didanosine,NRTI,HIV infection,Tablet,400 mg,Oral,Peripheral neuropathy,pancreatitis,Drugs that cause pancreatitis or peripheral neuropathy increase risk Can cause severe pancreatitis and peripheral neuropathy.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Digoxin,Cardiac Glycoside,Heart failure,Tablet,0.125 mg,Oral,atrial fibrillation,Nausea,Many drugs can increase levels (eg amiodarone verapamil) causing toxicity Can cause life-threatening arrhythmias due to its narrow therapeutic index.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Dihydroergotamine,Ergot Alkaloid,Migraine attacks,Solution,1 mg/mL,Intravenous,Nausea,vomiting,Strong CYP3A4 inhibitors (eg clarithromycin) are contraindicated due to risk of ergotism Contraindicated in coronary artery disease and uncontrolled hypertension.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Diltiazem,Non-Dihydropyridine CCB,Hypertension,Capsule (ER),120 mg,Oral,angina,Bradycardia,CYP3A4 inhibitors can increase levels and inducers can decrease levels Can cause bradycardia and heart failure.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Dimethyl Fumarate,Fumaric Acid Ester,Multiple sclerosis,Capsule (DR),240 mg,Oral,Flushing,abdominal pain,No significant drug interactions Can cause flushing and GI events (nausea diarrhea abdominal pain) usually at treatment initiation.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Dinoprostone,Prostaglandin,Cervical ripening,Insert,10 mg,Vaginal,labor induction,Uterine hyperstimulation,Other oxytocic agents may have additive effects Can cause uterine hyperstimulation which may progress to uterine rupture.,Refrigerate,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Diphenhydramine,Antihistamine,Allergic reactions,Capsule,25 mg,Oral,insomnia,Sedation,CNS depressants may enhance sedative effects May cause marked drowsiness and impair mental and physical abilities.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Diphenoxylate-Atropine,Antidiarrheal,Diarrhea,Tablet,2.5/0.025 mg,Oral,Sedation,dizziness,CNS depressants may enhance sedative effects Can cause paralytic ileus and toxic megacolon in patients with infectious diarrhea.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Dipyridamole,Antiplatelet,Post-cardiac valve replacement,Tablet,75 mg,Oral,Headache,dizziness,Theophylline may antagonize the antiplatelet effect Can cause angina pectoris and hypotension in patients with coronary artery disease.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Disopyramide,Antiarrhythmic (Class Ia),Ventricular arrhythmias,Capsule (CR),150 mg,Oral,Anticholinergic effects (dry mouth,urinary retention),Other drugs that prolong the QT interval increase risk of torsades de pointes Can cause heart failure and severe anticholinergic side effects.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Disulfiram,Aldehyde Dehydrogenase Inhibitor,Alcohol use disorder,Tablet,250 mg,Oral,Drowsiness,metallic taste,Metronidazole and alcohol-containing products can cause a disulfiram-like reaction Can cause hepatotoxicity and psychiatric disturbances.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Divalproex,Anticonvulsant,Seizures,Tablet (ER),500 mg,Oral,bipolar disorder,migraine prevention,CYP450 enzyme inducers may decrease levels Can cause severe hepatotoxicity and teratogenic effects including neural tube defects.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Neural tube defect risk),Prescription
Docetaxel,Antimicrotubule Agent,Breast cancer,Solution,20 mg/mL,Intravenous,other cancers,Myelosuppression,Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause severe fluid retention and myelosuppression.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Docusate,Stool Softener,Constipation,Capsule,100 mg,Oral,Abdominal cramping,diarrhea,Mineral oil may increase systemic absorption of the oil Can cause mild abdominal cramping.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Dofetilide,Antiarrhythmic (Class III),Atrial fibrillation/flutter,Capsule,125 mcg,Oral,Headache,dizziness,Many drugs are contraindicated including verapamil and cimetidine as they inhibit secretion and increase levels Can cause life-threatening ventricular arrhythmias particularly torsades de pointes.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Dolasetron,5-HT3 Antagonist,Chemotherapy-induced nausea/vomiting,Tablet,100 mg,Oral,Headache,diarrhea,Drugs that prolong the QT interval may have additive effects Can cause QT prolongation and subsequent arrhythmias.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Donepezil,Cholinesterase Inhibitor,Alzheimer's disease,Tablet,10 mg,Oral,Nausea,diarrhea,Other cholinergic agents can have additive effects Can cause nausea vomiting diarrhea and bradycardia.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Dopamine,Catecholamine,Shock,Solution,40 mg/mL,Intravenous,hypotension,Tachycardia,MAOIs can cause severe hypertension Extravasation can cause tissue necrosis and sloughing.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Doripenem,Carbapenem Antibiotic,Complicated infections,Powder for Injection,500 mg,Intravenous,Diarrhea,headache,Valproic acid levels may be significantly reduced Can cause seizures and hypersensitivity reactions.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Dornase Alfa,Mucolytic,Cystic fibrosis,Solution for Nebulization,2.5 mg/2.5 mL,Inhalation,Voice alteration,pharyngitis,No significant drug interactions For inhalation use only must be used with a recommended nebulizer.,Refrigerate Do Not Shake,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Doxazosin,Alpha-1 Blocker,Hypertension,Tablet,2 mg,Oral,BPH,Dizziness,Other antihypertensive drugs can have additive effects Can cause marked first-dose hypotension and syncope.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Doxepin,Tricyclic Antidepressant,Depression,Capsule,10 mg,Oral,insomnia,Pruritus,MAOIs can cause serotonin syndrome and hyperpyrexia Strong anticholinergic effects may occur with other drugs Increased risk of suicide in children and young adults.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Doxercalciferol,Vitamin D Analog,Hypoparathyroidism,Capsule,0.5 mcg,Oral,Hypercalcemia,headache,Cholestyramine may impair absorption Can cause hypercalcemia and hyperphosphatemia monitor serum levels.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information (Hypercalcemia risk),Prescription
Doxorubicin,Anthracycline Antibiotic,Various cancers,Solution,2 mg/mL,Intravenous,Myelosuppression,cardiotoxicity,Other cardiotoxic drugs (eg trastuzumab) increase risk Can cause severe and irreversible cardiotoxicity and myelosuppression.,Refrigerate Protect from light,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Doxycycline,Tetracycline Antibiotic,Bacterial infections,Tablet,100 mg,Oral,Photosensitivity,nausea,Antacids and calcium supplements decrease absorption Can cause photosensitivity and esophageal irritation.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Tooth discoloration risk),Prescription
Dronabinol,Cannabinoid,Chemotherapy-induced nausea/vomiting,Capsule,2.5 mg,Oral,appetite stimulation,Drowsiness,CNS depressants including alcohol can cause additive sedation Can cause profound psychological effects.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Droperidol,Antipsychotic,Nausea/vomiting,Solution,2.5 mg/mL,Intramuscular,sedation,QT prolongation,Other QT-prolonging agents increase risk of torsades de pointes Can cause QT prolongation and severe hypotension.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Drospirenone-Ethinyl Estradiol,Progestin + Estrogen,Contraception,Tablet,3/0.02 mg,Oral,Nausea,headache,ACE inhibitors and ARBs may increase risk of hyperkalemia Increases risk of thromboembolic disorders and hyperkalemia in high-risk patients.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Duloxetine,SNRI,Depression,Capsule,30 mg,Oral,anxiety,diabetic neuropathy,MAOIs can cause serotonin syndrome Can cause hepatotoxicity and increase suicidal thoughts and behaviors.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Dutasteride,5-alpha Reductase Inhibitor,BPH,Capsule,0.5 mg,Oral,Decreased libido,erectile dysfunction,Strong CYP3A4 inhibitors may increase levels Pregnant women should not handle crushed capsules due to risk of fetal abnormality.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Echinacea,Herbal Supplement,Immune support,Tablet,400 mg,Oral,cold symptoms,GI upset,May interact with drugs metabolized by CYP450 enzymes Not recommended for use in autoimmune diseases or with immunosuppressants.,Room Temperature,Animal studies have demonstrated safety,Insufficient data,No prescription required
Econazole,Antifungal,Fungal skin infections,Cream,1%,Topical,Skin irritation,burning,No significant drug interactions For topical use only not for ophthalmic use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Eculizumab,Monoclonal Antibody,Paroxysmal nocturnal hemoglobinuria (PNH),Solution,300 mg/30 mL,Intravenous,aHUS,Headache,Vaccination with live vaccines is not recommended Increases risk of serious meningococcal infections vaccination required at least 2 weeks prior.,Refrigerate Do Not Freeze Protect from light,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Efavirenz,NNRTI,HIV infection,Tablet,600 mg,Oral,Rash,dizziness,Induces CYP3A4 and inhibits CYP2C9/CYP2C19 affecting many drugs Can cause severe psychiatric symptoms and rash.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Eletriptan,5-HT1 Agonist,Migraine attacks,Tablet,40 mg,Oral,Chest pain,dizziness,Strong CYP3A4 inhibitors (eg ketoconazole) are contraindicated due to increased risk of coronary vasospasm Contraindicated in ischemic heart disease and uncontrolled hypertension.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Emedastine,Antihistamine,Allergic conjunctivitis,Solution,0.05%,Ophthalmic,Headache,burning sensation,No significant drug interactions For ophthalmic use only may cause mild transient stinging or burning.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Empagliflozin,SGLT2 Inhibitor,Type 2 diabetes,Tablet,25 mg,Oral,heart failure,Genital mycotic infections,Diuretics may enhance the potential for volume depletion Can cause genital mycotic infections and volume depletion.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information (Not recommended in 2nd/3rd trim),Prescription
Enalapril,ACE Inhibitor,Hypertension,Tablet,10 mg,Oral,heart failure,Cough,NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Risk of angioedema can occur at any time discontinue immediately.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information (ACE Inhibitor risk),Prescription
Enalapril-Hydrochlorothiazide,ACE Inhibitor + Thiazide Diuretic,Hypertension,Tablet,10/25 mg,Oral,Cough,dizziness,NSAIDs may diminish the antihypertensive effect Lithium levels may be increased May exacerbate glucose intolerance and hyperlipidemia.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information (ACE Inhibitor/Thiazide risk),Prescription
Enfuvirtide,Fusion Inhibitor,HIV infection,Powder for Injection,90 mg,Subcutaneous,Injection site reactions,insomnia,No significant drug interactions Almost all patients experience injection site reactions.,Refrigerate,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Enoxaparin,Low Molecular Weight Heparin,VTE prophylaxis and treatment,Solution,40 mg/0.4 mL,Subcutaneous,bleeding,anemia,Other drugs that affect hemostasis increase bleeding risk Can cause spinal or epidural hematoma leading to paralysis with neuraxial anesthesia.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Entacapone,COMT Inhibitor,Parkinson's disease,Tablet,200 mg,Oral,Diarrhea,urine discoloration,Nonselective MAOIs are contraindicated Can cause diarrhea and urine discoloration.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Entecavir,Nucleoside Reverse Transcriptase Inhibitor,Hepatitis B,Tablet,0.5 mg,Oral,Headache,fatigue,Drugs that reduce renal function may increase levels Severe acute exacerbations of hepatitis B have been reported upon discontinuation.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Enzalutamide,Androgen Receptor Inhibitor,Prostate cancer,Capsule,40 mg,Oral,Hot flashes,fatigue,Strong CYP2C8 inhibitors may increase levels and inducers may decrease levels Can cause seizures and posterior reversible encephalopathy syndrome (PRES).,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Epinastine,Antihistamine,Allergic conjunctivitis,Solution,0.05%,Ophthalmic,Headache,burning sensation,No significant drug interactions For ophthalmic use only may cause mild transient burning or stinging.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Epinephrine,Alpha/Beta Agonist,Anaphylaxis,Solution,1 mg/mL,Intramuscular,cardiac arrest,Tachycardia,Beta-blockers may antagonize cardiac effects and cause severe hypertension Can cause angina and arrhythmias in patients with heart disease.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Epirubicin,Anthracycline Antibiotic,Breast cancer,Solution,2 mg/mL,Intravenous,other cancers,Myelosuppression,Other cardiotoxic drugs (eg trastuzumab) increase risk Can cause severe and irreversible cardiotoxicity and myelosuppression.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Eplerenone,Aldosterone Antagonist,Heart failure,Tablet,25 mg,Oral,hypertension,Hyperkalemia,Strong CYP3A4 inhibitors (eg ketoconazole) are contraindicated Can cause hyperkalemia particularly in patients with renal impairment.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Epoetin Alfa,Erythropoiesis-Stimulating Agent,Anemia of chronic kidney disease,Solution,4000 units/mL,Subcutaneous,Hypertension,headache,No significant drug interactions Increases risk of serious cardiovascular events thromboembolic events and mortality when dosed to a target Hb over 11 g/dL.,Refrigerate Do Not Shake,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Eprosartan,ARB,Hypertension,Tablet,600 mg,Oral,Dizziness,upper respiratory infection,NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Use in pregnancy can cause injury and death to the developing fetus.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information (ARB risk),Prescription
Eptifibatide,Glycoprotein IIb/IIIa Inhibitor,Acute coronary syndrome,Solution,2 mg/mL,Intravenous,Bleeding,hypotension,Other drugs that affect hemostasis increase bleeding risk Can cause serious bleeding and thrombocytopenia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Ergocalciferol,Vitamin D,Vitamin D deficiency,000 unit,50,Capsule,Hypercalcemia,Hypercalcemia,Cholestyramine and mineral oil may reduce absorption Excessive intake can lead to hypercalcemia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information (Hypercalcemia risk),Oral
Ergoloid Mesylates,Ergot Alkaloid,Dementia (cognitive decline),Tablet,1 mg,Oral,Nausea,headache,No significant drug interactions Not for use in the treatment of psychosis or acute mental disorders.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Ergotamine,Ergot Alkaloid,Migraine attacks,Tablet,1 mg,Sublingual,Nausea,vomiting,Strong CYP3A4 inhibitors (eg clarithromycin) are contraindicated due to risk of ergotism Contraindicated in coronary artery disease and uncontrolled hypertension.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Ertapenem,Carbapenem Antibiotic,Bacterial infections,Powder for Injection,1 g,Intramuscular,Diarrhea,infusion site reactions,Valproic acid levels may be significantly reduced Can cause seizures and hypersensitivity reactions.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Erythromycin,Macrolide Antibiotic,Bacterial infections,Tablet,500 mg,Oral,Nausea,vomiting,Inhibits CYP3A4 increasing levels of many drugs (eg statins carbamazepine) May cause QT prolongation and subsequent arrhythmias.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Escitalopram,SSRI,Depression,Tablet,10 mg,Oral,anxiety disorders,Nausea,MAOIs can cause serotonin syndrome and other SSRIs may have additive effects May increase risk of bleeding especially with NSAIDs or warfarin.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Esmolol,Beta-Blocker,Tachycardia,Solution,10 mg/mL,Intravenous,supraventricular tachycardia,Hypotension,Other drugs that lower heart rate or blood pressure can have additive effects Can cause profound hypotension and bradycardia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Esomeprazole,Proton Pump Inhibitor,GERD,Capsule (DR),40 mg,Oral,erosive esophagitis,Headache,Can reduce absorption of drugs requiring gastric pH for absorption (eg ketoconazole) May increase risk of Clostridium difficile-associated diarrhea and bone fractures with long-term use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Estazolam,Benzodiazepine,Insomnia,Tablet,1 mg,Oral,Sedation,dizziness,CNS depressants including alcohol and opioids increase sedation risk Abrupt discontinuation can cause withdrawal symptoms.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Estradiol,Estrogen,Hormone replacement,Tablet,1 mg,Oral,osteoporosis prevention,Breast tenderness,Inducers of CYP450 enzymes (eg carbamazepine) may decrease estrogen levels Increases risk of thromboembolic disorders and endometrial cancer.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Eszopiclone,Non-Benzodiazepine Hypnotic,Insomnia,Tablet,2 mg,Oral,Unpleasant taste,headache,CNS depressants including alcohol increase sedation risk May cause complex sleep behaviors like sleep-driving.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Ethambutol,Antimycobacterial,Tuberculosis,Tablet,400 mg,Oral,Optic neuritis,hyperuricemia,Aluminum hydroxide may decrease absorption Can cause optic neuritis leading to decreased visual acuity and color blindness.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Ethosuximide,Anticonvulsant,Absence seizures,Capsule,250 mg,Oral,Drowsiness,dizziness,CNS depressants may enhance sedative effects Can cause blood dyscrasias including aplastic anemia and SLE.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Etodolac,NSAID,Osteoarthritis,Tablet,400 mg,Oral,pain,GI upset,ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (NSAID risk),Prescription
Etonogestrel,Progestin,Contraception (implant),Implant,68 mg,Subdermal,Headache,weight gain,Hepatic enzyme inducers may decrease efficacy and increase breakthrough bleeding Must be removed if a patient becomes pregnant.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Implant),Prescription
Etoposide,Topoisomerase Inhibitor,Various cancers,Capsule,50 mg,Oral,Myelosuppression,nausea,Other bone marrow suppressants may have additive effects Can cause severe myelosuppression and secondary leukemias.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Everolimus,mTOR Inhibitor,Organ transplant rejection,Tablet,5 mg,Oral,certain cancers,Stomatitis,Strong CYP3A4 or P-gp inhibitors may increase levels and inducers may decrease levels Can cause non-infectious pneumonitis and immunosuppression.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Exemestane,Aromatase Inhibitor,Breast cancer,Tablet,25 mg,Oral,Hot flashes,fatigue,Estrogen-containing medications should not be used Decreases bone mineral density increasing fracture risk.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Exenatide,GLP-1 Receptor Agonist,Type 2 diabetes,Solution,10 mcg/0.4 mL,Subcutaneous,Nausea,hypoglycemia,Drugs that are rapidly absorbed may be delayed (eg antibiotics) Can cause nausea and increased risk of thyroid C-cell tumors in rodents.,Refrigerate,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Ezetimibe,Cholesterol Absorption Inhibitor,Hyperlipidemia,Tablet,10 mg,Oral,Diarrhea,arthralgia,Cholestyramine decreases ezetimibe levels Fibrates may increase the risk of cholelithiasis.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Famciclovir,Antiviral,Herpes zoster,Tablet,500 mg,Oral,herpes simplex,Headache,Probenecid may decrease renal excretion of penciclovir Dosage adjustment is required in renal impairment.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Famotidine,H2 Blocker,Peptic ulcer disease,Tablet,20 mg,Oral,GERD,Headache,No significant drug interactions May cause confusion more commonly in elderly or severely ill patients.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Felbamate,Anticonvulsant,Seizures,Tablet,400 mg,Oral,Anorexia,insomnia,Increases levels of phenytoin and valproic acid and decreases levels of carbamazepine Can cause aplastic anemia and hepatic failure.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Felodipine,Dihydropyridine CCB,Hypertension,Tablet (ER),5 mg,Oral,Peripheral edema,headache,Strong CYP3A4 inhibitors (eg ketoconazole) can significantly increase levels Can cause peripheral edema and gingival hyperplasia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Fenofibrate,Fibrate,Hypertriglyceridemia,Tablet,145 mg,Oral,Nausea,rash,Can potentiate the effects of warfarin increasing INR Can cause cholelithiasis and myopathy.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Fentanyl,Opioid Agonist,Pain management,Patch,25 mcg/hr,Transdermal,Constipation,nausea,CNS depressants including alcohol and benzodiazepines increase sedation risk Life-threatening respiratory depression may occur.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Opioid risk),Prescription
Ferrous Sulfate,Iron Supplement,Iron deficiency anemia,Tablet,325 mg,Oral,Constipation,nausea,Antacids and tetracyclines decrease absorption Can cause GI irritation and constipation.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,No prescription required
Fesoterodine,Anticholinergic,Overactive bladder,Tablet,4 mg,Oral,Dry mouth,constipation,Strong CYP3A4 inhibitors may increase levels Can cause urinary retention and blurred vision.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Fexofenadine,Antihistamine,Allergic rhinitis,Tablet,180 mg,Oral,urticaria,Headache,Aluminum and magnesium-containing antacids decrease absorption Rarely may cause headache or drowsiness.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Finasteride,5-alpha Reductase Inhibitor,BPH,Tablet,5 mg,Oral,male pattern hair loss,Decreased libido,No significant drug interactions Pregnant women should not handle crushed tablets due to risk of fetal abnormality.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Flecainide,Antiarrhythmic (Class Ic),Ventricular arrhythmias,Tablet,100 mg,Oral,atrial fibrillation,Dizziness,Other drugs that prolong the QT interval increase risk of proarrhythmia Can cause new or worsened arrhythmias.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Fluconazole,Azole Antifungal,Fungal infections,Tablet,150 mg,Oral,Headache,nausea,Inhibits CYP2C9 and CYP3A4 increasing levels of many drugs (eg warfarin phenytoin) Can cause QT prolongation and subsequent arrhythmias.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Fludarabine,Antimetabolite,Chronic lymphocytic leukemia (CLL),Tablet,50 mg,Oral,Myelosuppression,fever,Other bone marrow suppressants may have additive effects Can cause severe myelosuppression and neurotoxicity.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Fludrocortisone,Corticosteroid,Adrenal insufficiency,Tablet,0.1 mg,Oral,Hyperglycemia,fluid retention,Other drugs that lower potassium may have additive effects Can cause hypertension and hypokalemia.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Flumazenil,Benzodiazepine Antagonist,Benzodiazepine overdose,Solution,0.1 mg/mL,Intravenous,Dizziness,nausea,Can precipitate acute withdrawal in patients dependent on benzodiazepines Seizures may occur especially in patients on long-term benzodiazepines.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Fluocinolone,Topical Corticosteroid,Inflammatory skin conditions,Solution,0.01%,Topical,Skin atrophy,burning,No significant drug interactions Systemic absorption can occur with extensive use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Fluocinonide,Topical Corticosteroid,Inflammatory skin conditions,Cream,0.05%,Topical,Skin atrophy,burning,No significant drug interactions Systemic absorption can occur with extensive use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Fluorometholone,Corticosteroid,Inflammatory eye conditions,Suspension,0.10%,Ophthalmic,Increased intraocular pressure,blurred vision,No significant drug interactions May increase intraocular pressure and cause cataract formation with prolonged use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Fluorouracil,Antimetabolite,Various cancers,Powder for Injection,500 mg,Intravenous,Myelosuppression,mucositis,Leucovorin enhances the toxicity and efficacy Can cause severe myelosuppression and mucositis.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Fluoxetine,SSRI,Depression,Capsule,20 mg,Oral,OCD,panic disorder,MAOIs can cause serotonin syndrome and other SSRIs may have additive effects May increase risk of bleeding especially with NSAIDs or warfarin.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Fluphenazine,Typical Antipsychotic,Psychotic disorders,Tablet,5 mg,Oral,Extrapyramidal symptoms,sedation,CNS depressants may enhance sedative effects Can cause extrapyramidal symptoms and neuroleptic malignant syndrome.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Flurazepam,Benzodiazepine,Insomnia,Capsule,15 mg,Oral,Sedation,dizziness,CNS depressants including alcohol and opioids increase sedation risk Abrupt discontinuation can cause withdrawal symptoms.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Flurbiprofen,NSAID,Pain,Tablet,100 mg,Oral,inflammation,osteoarthritis,ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (NSAID risk),Prescription
Flutamide,Antiandrogen,Prostate cancer,Capsule,125 mg,Oral,Hot flashes,loss of libido,Warfarin metabolism is inhibited increasing INR Can cause hepatotoxicity and gynecomastia.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Fluticasone,Inhaled Corticosteroid,Asthma,Inhaler,110 mcg/actuation,Inhalation,COPD,Oral candidiasis,Strong CYP3A4 inhibitors like ketoconazole may increase systemic exposure Rinse mouth after inhalation to prevent oral candidiasis.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Fluvastatin,Statin,Hyperlipidemia,Capsule (ER),80 mg,Oral,Headache,myalgia,Can increase the effects of warfarin and other drugs metabolized by CYP2C9 Can cause myopathy and rhabdomyolysis.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Fluvoxamine,SSRI,Obsessive-compulsive disorder (OCD),Tablet,100 mg,Oral,Nausea,somnolence,Strong inhibitor of CYP1A2 and CYP2C19 affecting many drugs (eg theophylline clozapine) May increase risk of bleeding especially with NSAIDs or warfarin.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Folic Acid,Vitamin,Folate deficiency,Tablet,1 mg,Oral,megaloblastic anemia,Nausea,Folate antagonists like methotrexate are inhibited Can mask the hematological signs of vitamin B12 deficiency.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,No prescription required
Formoterol,LABA,Asthma,Capsule for Inhalation,12 mcg,Inhalation,COPD,Headache,Other adrenergic drugs can have additive cardiovascular effects Can cause paradoxical bronchospasm and increase the risk of asthma-related death.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Fosamprenavir,Protease Inhibitor,HIV infection,Tablet,700 mg,Oral,Rash,nausea,Induces CYP3A4 and inhibits CYP2C9 affecting many drugs Can cause severe skin reactions and hepatotoxicity.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Foscarnet,Antiviral,Cytomegalovirus (CMV) retinitis,Solution,24 mg/mL,Intravenous,Nephrotoxicity,electrolyte imbalances,Nephrotoxic drugs increase risk of renal impairment Can cause renal impairment and electrolyte imbalances.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Fosfomycin,Antibiotic,Uncomplicated UTIs,Packet,3 g,Oral,Diarrhea,nausea,Metoclopramide may decrease serum levels Generally well-tolerated with diarrhea being the most common side effect.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Fosphenytoin,Anticonvulsant,Seizures,Solution,50 mg PE/mL,Intravenous,status epilepticus,Nystagmus,Many drugs can increase or decrease phenytoin levels Can cause life-threatening dermatologic reactions like Stevens-Johnson syndrome.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Frovatriptan,5-HT1 Agonist,Migraine attacks,Tablet,2.5 mg,Oral,Dizziness,fatigue,Other 5-HT1 agonists can have additive effects Contraindicated in ischemic heart disease and uncontrolled hypertension.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Fulvestrant,Estrogen Receptor Antagonist,Breast cancer,Solution,250 mg/5 mL,Intramuscular,Nausea,hot flashes,No significant drug interactions Can cause injection site reactions and nausea.,Refrigerate,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Furosemide,Loop Diuretic,Edema (heart failure,Tablet,40 mg,Oral,hepatic,renal),Other ototoxic drugs may increase risk of hearing loss NSAIDs may reduce the diuretic effect Profound diuresis and electrolyte depletion can occur.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Gabapentin,Anticonvulsant,Seizures,Tablet,600 mg,Oral,neuropathic pain,Dizziness,Antacids decrease absorption May cause somnolence dizziness and respiratory depression especially with opioids.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Gadobutrol,Contrast Agent,MRI contrast,Solution,1 mmol/10 mL,Intravenous,Headache,nausea,No significant drug interactions Contraindicated in patients with known gadolinium sensitivity.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Ganciclovir,Antiviral,Cytomegalovirus (CMV) infections,Capsule,500 mg,Oral,Myelosuppression,fever,Other bone marrow suppressants may have additive effects Can cause severe myelosuppression and mutagenesis.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Gefitinib,Kinase Inhibitor,Non-small cell lung cancer (NSCLC),Tablet,250 mg,Oral,Diarrhea,rash,Strong CYP3A4 inducers may decrease efficacy Can cause interstitial lung disease and diarrhea.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Gemcitabine,Antimetabolite,Pancreatic cancer,Powder for Injection,200 mg,Intravenous,other cancers,Myelosuppression,Other bone marrow suppressants may have additive effects Can cause severe myelosuppression and hemolytic uremic syndrome.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Gemfibrozil,Fibrate,Hypertriglyceridemia,Tablet,600 mg,Oral,Dyspepsia,abdominal pain,Potentiates the effects of warfarin and increases risk of myopathy with statins Can cause cholelithiasis and myopathy.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Gentamicin,Aminoglycoside Antibiotic,Bacterial infections,Ointment,0.10%,Ophthalmic,Nephrotoxicity,ototoxicity,Other nephrotoxic or ototoxic drugs increase risk of toxicity Monitor peak and trough levels to minimize risk of nephrotoxicity and ototoxicity.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Aminoglycoside risk of ototoxicity),Prescription
Glatiramer,Immunomodulator,Multiple sclerosis,Solution,20 mg/mL,Subcutaneous,Injection site reactions,flushing,No significant drug reactions Can cause immediate post-injection reaction (flushing chest pain palpitations).,Refrigerate,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Glibenclamide,Sulfonylurea,Type 2 diabetes,Tablet,5 mg,Oral,Hypoglycemia,nausea,Drugs that increase hypoglycemia risk (eg beta-blockers) Can cause severe and prolonged hypoglycemia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information (Sulfonylurea risk of hypoglycemia),Prescription
Gliclazide,Sulfonylurea,Type 2 diabetes,Tablet,80 mg,Oral,Hypoglycemia,nausea,Drugs that increase hypoglycemia risk (eg beta-blockers) Can cause hypoglycemia.,Room Temperature,Animal studies have demonstrated safety,Not FDA approved; generally considered C,Prescription
Glimepiride,Sulfonylurea,Type 2 diabetes,Tablet,2 mg,Oral,Hypoglycemia,nausea,Drugs that increase hypoglycemia risk (eg beta-blockers) Can cause severe and prolonged hypoglycemia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information (Sulfonylurea risk of hypoglycemia),Prescription
Glipizide,Sulfonylurea,Type 2 diabetes,Tablet,5 mg,Oral,Hypoglycemia,nausea,Drugs that increase hypoglycemia risk (eg beta-blockers) Can cause hypoglycemia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information (Sulfonylurea risk of hypoglycemia),Prescription
Glucagon,Hyperglycemic Agent,Severe hypoglycemia,Powder for Injection,1 mg,Subcutaneous,Nausea,vomiting,No significant drug interactions Administer glucose upon recovery to prevent rebound hypoglycemia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Glyburide,Sulfonylurea,Type 2 diabetes,Tablet,5 mg,Oral,Hypoglycemia,nausea,Drugs that increase hypoglycemia risk (eg beta-blockers) Can cause severe and prolonged hypoglycemia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information (Sulfonylurea risk of hypoglycemia),Prescription
Golimumab,TNF Blocker,Autoimmune disorders (RA,Solution,50 mg/0.5 mL,Subcutaneous,psoriatic arthritis),Upper respiratory infection,Live vaccines should not be given concurrently due to increased risk of infection Serious infections including tuberculosis and invasive fungal infections may occur.,Refrigerate,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Goserelin,GnRH Agonist,Prostate cancer,Implant,3.6 mg,Subcutaneous,breast cancer,endometriosis,No significant drug interactions Causes an initial increase in testosterone levels which may worsen symptoms in prostate cancer patients.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Granisetron,5-HT3 Antagonist,Chemotherapy-induced nausea/vomiting,Tablet,1 mg,Oral,Headache,constipation,No significant drug interactions Generally well-tolerated with headache being the most common side effect.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Griseofulvin,Antifungal,Fungal infections of skin,Tablet,500 mg,Oral,hair,nails,Warfarin metabolism is decreased increasing INR Can cause photosensitivity and lupus-like syndrome.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Guanfacine,Alpha-2 Agonist,Hypertension,Tablet,1 mg,Oral,ADHD,Sedation,CNS depressants may enhance sedative effects Abrupt discontinuation can cause rebound hypertension and nervousness.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Halobetasol,Topical Corticosteroid,Inflammatory skin conditions,Ointment,0.05%,Topical,Skin atrophy,burning,No significant drug interactions Systemic absorption can occur with extensive use leading to adrenal suppression.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Haloperidol,Typical Antipsychotic,Psychotic disorders,Tablet,5 mg,Oral,Tourette's syndrome,Extrapyramidal symptoms,CNS depressants may enhance sedative effects Can cause extrapyramidal symptoms and QT prolongation.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Heparin,Anticoagulant,VTE prophylaxis and treatment,Solution,5000 units/mL,Subcutaneous,bleeding,heparin-induced thrombocytopenia,Other drugs that affect hemostasis increase bleeding risk Can cause heparin-induced thrombocytopenia (HIT) and bleeding.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Homatropine,Anticholinergic,Ocular cycloplegia,Solution,5%,Ophthalmic,mydriasis,Blurred vision,Other anticholinergic drugs can have additive effects Contraindicated in patients with angle-closure glaucoma.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Hydralazine,Vasodilator,Hypertension,Tablet,25 mg,Oral,Headache,tachycardia,MAOIs may cause excessive hypotension Can cause drug-induced lupus erythematosus and peripheral neuropathy.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Hydrochlorothiazide,Thiazide Diuretic,Hypertension,Tablet,25 mg,Oral,edema,Hypokalemia,Other antihypertensive drugs can have additive effects Lithium levels may be increased Can cause hypokalemia and hyponatremia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information (Thiazide risk),Prescription
Hydrocodone,Opioid Agonist,Pain,Tablet,5 mg,Oral,Cough,constipation,CNS depressants including alcohol and benzodiazepines increase sedation risk Life-threatening respiratory depression may occur.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Opioid risk),Prescription
Hydrocortisone,Corticosteroid,Inflammatory conditions,Cream,1%,Topical,adrenal insufficiency,Hyperglycemia,CYP3A4 inducers (eg phenytoin) may decrease efficacy and inhibitors may increase effects Can cause hyperglycemia and adrenal suppression with prolonged use.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,No prescription required/Prescription
Hydromorphone,Opioid Agonist,Pain,Tablet,2 mg,Oral,Constipation,nausea,CNS depressants including alcohol and benzodiazepines increase sedation risk Life-threatening respiratory depression may occur.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Opioid risk),Prescription
Hydroxychloroquine,Antimalarial / DMARD,Malaria,Tablet,200 mg,Oral,lupus,rheumatoid arthritis,Can cause retinal toxicity requiring regular ophthalmologic exams Can cause retinal toxicity and QT prolongation.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Hydroxyurea,Antimetabolite,Sickle cell anemia,Capsule,500 mg,Oral,certain cancers,Myelosuppression,Other bone marrow suppressants may have additive effects Can cause severe myelosuppression and macrocytic anemia.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Hydroxyzine,Antihistamine,Anxiety,Tablet,25 mg,Oral,pruritus,Sedation,CNS depressants may enhance sedative effects May cause marked drowsiness and QT prolongation.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Hyoscyamine,Anticholinergic,GI spasms,Tablet,0.125 mg,Oral,irritable bowel syndrome,Dry mouth,Other anticholinergic drugs can have additive effects Contraindicated in patients with glaucoma or severe ulcerative colitis.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Ibandronate,Bisphosphonate,Osteoporosis,Tablet,150 mg,Oral,Esophageal irritation,musculoskeletal pain,Calcium supplements and other oral medications can interfere with absorption Risk of esophageal irritation and osteonecrosis of the jaw.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Ibrutinib,BTK Inhibitor,Chronic lymphocytic leukemia (CLL),Capsule,140 mg,Oral,mantle cell lymphoma,Bleeding,Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause bleeding infections and atrial fibrillation.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Ibuprofen,NSAID,Pain,Tablet,600 mg,Oral,fever,inflammation,ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (NSAID risk),No prescription required/Prescription
Ibutilide,Antiarrhythmic (Class III),Atrial fibrillation/flutter,Solution,0.1 mg/mL,Intravenous,Headache,nausea,Other drugs that prolong the QT interval increase risk of torsades de pointes Can cause life-threatening ventricular arrhythmias particularly torsades de pointes.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Idarubicin,Anthracycline Antibiotic,Leukemias,Solution,5 mg/mL,Intravenous,Myelosuppression,cardiotoxicity,Other cardiotoxic drugs (eg trastuzumab) increase risk Can cause severe and irreversible cardiotoxicity and myelosuppression.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Ifosfamide,Alkylating Agent,Various cancers,Powder for Injection,1 g,Intravenous,Myelosuppression,hemorrhagic cystitis,Other bone marrow suppressants may have additive effects Can cause hemorrhagic cystitis (requires Mesna) and neurotoxicity.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Iloperidone,Atypical Antipsychotic,Schizophrenia,Tablet,2 mg,Oral,Dizziness,dry mouth,Strong CYP2D6 or CYP3A4 inhibitors require dose adjustment Can cause orthostatic hypotension and QT prolongation.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Imatinib,Kinase Inhibitor,Chronic myeloid leukemia (CML),Tablet,400 mg,Oral,GI stromal tumor,Fluid retention,Strong CYP3A4 inducers may decrease efficacy Can cause fluid retention and myelosuppression.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Imipenem-Cilastatin,Carbapenem Antibiotic,Serious bacterial infections,Powder for Injection,500 mg,Intravenous,Nausea,diarrhea,Valproic acid levels may be significantly reduced Can cause seizures and hypersensitivity reactions.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Imipramine,Tricyclic Antidepressant,Depression,Tablet,25 mg,Oral,enuresis,Dry mouth,MAOIs can cause serotonin syndrome and hyperpyrexia Strong anticholinergic effects may occur with other drugs Increased risk of suicide in children and young adults.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Indapamide,Thiazide-like Diuretic,Hypertension,Tablet,2.5 mg,Oral,Hypokalemia,dizziness,Other antihypertensive drugs can have additive effects Lithium levels may be increased Can cause hypokalemia and hyponatremia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information (Thiazide-like risk),Prescription
Indomethacin,NSAID,Gout,Capsule,50 mg,Oral,pain,inflammation,ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (NSAID risk),Prescription
Infliximab,TNF Blocker,Autoimmune disorders (Crohn's,Powder for Injection,100 mg,Intravenous,RA),Infusion reactions,Live vaccines should not be given concurrently due to increased risk of infection Serious infections including tuberculosis and invasive fungal infections may occur.,Refrigerate,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Insulin Aspart,Insulin (Rapid-Acting),Diabetes mellitus,Solution,100 unit/mL,Subcutaneous,Hypoglycemia,weight gain,Drugs that affect glucose metabolism (eg corticosteroids beta-blockers) Can cause severe hypoglycemia and hypokalemia.,Refrigerate,Human studies have proved safety,FDA Prescribing Information,Prescription
Insulin Detemir,Insulin (Long-Acting),Diabetes mellitus,Solution,100 unit/mL,Subcutaneous,Hypoglycemia,weight gain,Drugs that affect glucose metabolism (eg corticosteroids beta-blockers) Can cause severe hypoglycemia and hypokalemia.,Refrigerate,Human studies have proved safety,FDA Prescribing Information,Prescription
Insulin Glulisine,Insulin (Rapid-Acting),Diabetes mellitus,Solution,100 unit/mL,Subcutaneous,Hypoglycemia,weight gain,Drugs that affect glucose metabolism (eg corticosteroids beta-blockers) Can cause severe hypoglycemia and hypokalemia.,Refrigerate,Human studies have proved safety,FDA Prescribing Information,Prescription
Insulin Lispro,Insulin (Rapid-Acting),Diabetes mellitus,Solution,100 unit/mL,Subcutaneous,Hypoglycemia,weight gain,Drugs that affect glucose metabolism (eg corticosteroids beta-blockers) Can cause severe hypoglycemia and hypokalemia.,Refrigerate,Human studies have proved safety,FDA Prescribing Information,Prescription
Interferon Alfa-2b,Immunomodulator,Hepatitis B/C,Powder for Injection,10 million unit,Subcutaneous,certain cancers,Flu-like symptoms,Theophylline clearance may be decreased Can cause severe psychiatric effects and myelosuppression.,Refrigerate,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Ipratropium,Anticholinergic,COPD,Solution for Nebulization,0.03%,Inhalation,asthma,Dry mouth,Other anticholinergic drugs can have additive effects Can cause paradoxical bronchospasm and narrow-angle glaucoma.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Irbesartan,ARB,Hypertension,Tablet,150 mg,Oral,diabetic nephropathy,Hyperkalemia,NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Use in pregnancy can cause injury and death to the developing fetus.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information (ARB risk),Prescription
Irinotecan,Topoisomerase Inhibitor,Colorectal cancer,Solution,20 mg/mL,Intravenous,Diarrhea,myelosuppression,Strong CYP3A4 inducers or inhibitors may alter levels Can cause severe delayed diarrhea and myelosuppression.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Isavuconazole,Azole Antifungal,Invasive fungal infections,Capsule,200 mg,Oral,Nausea,vomiting,Strong CYP3A4 inducers may decrease efficacy Can cause hepatotoxicity and infusion-related reactions.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Isoniazid,Antimycobacterial,Tuberculosis,Tablet,300 mg,Oral,Hepatotoxicity,peripheral neuropathy,Inhibits CYP450 enzymes increasing levels of many drugs (eg phenytoin) Can cause severe hepatotoxicity and peripheral neuropathy.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Isosorbide Dinitrate,Nitrate,Angina pectoris,Tablet,20 mg,Oral,Headache,hypotension,Phosphodiesterase inhibitors (eg sildenafil) can cause severe hypotension Can cause tolerance with continuous use and severe headaches.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Isosorbide Mononitrate,Nitrate,Angina pectoris,Tablet,30 mg,Oral,Headache,hypotension,Phosphodiesterase inhibitors (eg sildenafil) can cause severe hypotension Can cause tolerance with continuous use and severe headaches.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Isotretinoin,Retinoid,Severe nodular acne,Capsule,40 mg,Oral,Dry skin,cheilitis,Vitamin A supplements can cause additive toxicity and tetracyclines increase risk of pseudotumor cerebri Highly teratogenic requires strict pregnancy prevention program.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information (iPLEDGE program),Prescription
Itraconazole,Azole Antifungal,Fungal infections,Capsule,100 mg,Oral,Nausea,rash,Inhibits CYP3A4 increasing levels of many drugs (eg statins) Contraindicated with drugs that prolong QT interval and can cause negative inotropy and heart failure.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Ivabradine,Hyperpolarization-Activated Cyclic NucleotideGated (HCN) Channel Blocker,Heart failure,Tablet,5 mg,Oral,angina,Bradycardia,Strong CYP3A4 inhibitors may increase levels Can cause bradycardia and phosphenes (visual brightness).,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Ivacaftor,CFTR Potentiator,Cystic fibrosis,Tablet,150 mg,Oral,Headache,upper respiratory infection,Strong CYP3A4 inhibitors may increase levels Can cause elevated liver enzymes and non-congenital cataracts.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Ivermectin,Anthelmintic,Parasitic infections,Tablet,3 mg,Oral,Dizziness,pruritus,No significant drug interactions Can cause Mazzotti reaction (inflammatory response) in patients with high parasitic load.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Ketoconazole,Azole Antifungal,Fungal infections,Tablet,200 mg,Oral,Nausea,vomiting,Strong CYP3A4 inhibitor that can significantly increase levels of many drugs (eg statins) Contraindicated due to risk of hepatotoxicity and adrenal insufficiency.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Ketoprofen,NSAID,Pain,Capsule,75 mg,Oral,inflammation,osteoarthritis,ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (NSAID risk),Prescription
Ketorolac,NSAID,Pain (short-term management),Tablet,10 mg,Oral,GI upset,nausea,ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious bleeding and renal impairment.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information (NSAID risk),Prescription
Ketotifen,Antihistamine / Mast Cell Stabilizer,Allergic conjunctivitis,Solution,0.03%,Ophthalmic,Drowsiness,dry eyes,CNS depressants may enhance sedative effects For ophthalmic use only may cause transient stinging.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Labetalol,Alpha/Beta-Blocker,Hypertension,Tablet,200 mg,Oral,Bradycardia,fatigue,Other drugs that lower heart rate or blood pressure can have additive effects Can cause liver injury and bronchospasm in susceptible patients.,Room Temperature,Human studies have proved safety,FDA Prescribing Information (Beta-blocker risk),Prescription
Lacosamide,Anticonvulsant,Seizures,Tablet,100 mg,Oral,Dizziness,headache,No significant drug interactions May cause dizziness and PR interval prolongation.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Lamivudine,NRTI,HIV infection,Tablet,150 mg,Oral,Hepatitis B,Headache,Trimethoprim/sulfamethoxazole increases lamivudine exposure Severe acute exacerbations of hepatitis B have been reported upon discontinuation.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Lamotrigine,Anticonvulsant,Seizures,Tablet,100 mg,Oral,bipolar disorder,Dizziness,Valproic acid increases lamotrigine levels while carbamazepine decreases them Can cause serious skin rashes including Stevens-Johnson syndrome.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Lansoprazole,Proton Pump Inhibitor,GERD,Capsule (DR),30 mg,Oral,erosive esophagitis,Diarrhea,Can reduce absorption of drugs requiring gastric pH for absorption (eg ketoconazole) May increase risk of Clostridium difficile-associated diarrhea and bone fractures with long-term use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Latanoprost,Prostaglandin Analog,Glaucoma,Solution,0.01%,Ophthalmic,ocular hypertension,Eye color change,No significant drug interactions Can cause increased pigmentation of the iris and eyelashes.,Refrigerate,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Leflunomide,DMARD,Rheumatoid arthritis,Tablet,20 mg,Ooral,Diarrhea,elevated LFTs,Activated charcoal or cholestyramine can accelerate elimination Can cause hepatotoxicity and teratogenicity.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Letrozole,Aromatase Inhibitor,Breast cancer,Tablet,2.5 mg,Oral,Hot flashes,arthralgia,Tamoxifen may reduce letrozole levels Estrogen-containing medications should not be used Decreases bone mineral density increasing fracture risk.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Leuprolide,GnRH Agonist,Prostate cancer,Powder for Injection,3.75 mg,Intramuscular,endometriosis,uterine fibroids,No significant drug interactions Causes an initial increase in testosterone levels which may worsen symptoms in prostate cancer patients.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Levalbuterol,SABA,Asthma,Solution for Nebulization,0.63 mg/3 mL,Inhalation,bronchospasm,Tachycardia,Beta-blockers may antagonize the effects Can cause paradoxical bronchospasm and cardiovascular effects.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Levetiracetam,Anticonvulsant,Seizures,Tablet,500 mg,Oral,Somnolence,dizziness,No significant drug interactions May cause behavioral abnormalities including psychosis and aggression.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Levocabastine,Antihistamine,Allergic conjunctivitis,Suspension,0.05%,Ophthalmic,Headache,burning sensation,No significant drug interactions For ophthalmic use only may cause mild transient stinging.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Levocarnitine,Carnitine Supplement,Carnitine deficiency,Solution,1 g/10 mL,Oral,Nausea,vomiting,No significant drug interactions Can cause nausea and vomiting.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Levocetirizine,Antihistamine,Allergic rhinitis,Tablet,5 mg,Oral,urticaria,Somnolence,No significant drug interactions at recommended doses Rarely may cause somnolence.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Levodopa,Dopamine Precursor,Parkinson's disease,Tablet,100 mg,Oral,Nausea,dizziness,Nonselective MAOIs are contraindicated and pyridoxine can reverse its effects in the periphery Can cause orthostatic hypotension and hallucinations.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Levofloxacin,Fluoroquinolone Antibiotic,Bacterial infections,Tablet,500 mg,Oral,Nausea,diarrhea,Chelates with divalent cations (antacids Ca2+ Fe2+) reducing absorption May enhance effects of warfarin Associated with tendonitis and tendon rupture.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information (Arthropathy risk in animals),Prescription
Levothyroxine,Thyroid Hormone,Hypothyroidism,Tablet,50 mcg,Oral,Palpitations,weight loss,Many drugs can decrease absorption (eg calcium iron) Can cause cardiac ischemia and arrhythmias in overdose.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Lidocaine,Local Anesthetic / Antiarrhythmic (Class Ib),Local anesthesia,Jelly,2%,Topical,ventricular arrhythmias,CNS toxicity (dizziness,Beta-blockers may increase the risk of lidocaine toxicity Can cause CNS toxicity (seizures) and cardiovascular collapse.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Linagliptin,DPP-4 Inhibitor,Type 2 diabetes,Tablet,5 mg,Oral,Nasopharyngitis,headache,No significant drug interactions May cause hypersensitivity reactions including anaphylaxis.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Linezolid,Oxazolidinone Antibiotic,Bacterial infections (e.g.,Tablet,600 mg,Oral,VRE),Diarrhea,Can cause serotonin syndrome with serotonergic drugs like SSRIs Can cause myelosuppression and peripheral neuropathy.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Liothyronine,Thyroid Hormone,Hypothyroidism,Tablet,5 mcg,Oral,Palpitations,weight loss,Many drugs can decrease absorption (eg calcium iron) Can cause cardiac ischemia and arrhythmias in overdose.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Liotrix,Thyroid Hormone,Hypothyroidism,Tablet,15/60 mcg,Oral,Palpitations,weight loss,Many drugs can decrease absorption (eg calcium iron) Can cause cardiac ischemia and arrhythmias in overdose.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Lisinopril,ACE Inhibitor,Hypertension,Tablet,10 mg,Oral,heart failure,Cough,NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Risk of angioedema can occur at any time discontinue immediately.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information (ACE Inhibitor risk),Prescription
Lithium,Antimanic,Bipolar disorder,Capsule,300 mg,Oral,Nausea,tremor,NSAIDs and diuretics can decrease renal clearance and increase levels Can cause lithium toxicity which requires monitoring of serum levels.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Cardiac risk),Prescription
Lodoxamide,Mast Cell Stabilizer,Allergic conjunctivitis,Solution,0.10%,Ophthalmic,Burning,stinging,No significant drug interactions For ophthalmic use only may cause transient burning or stinging.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Lomefloxacin,Fluoroquinolone Antibiotic,Bacterial infections,Tablet,400 mg,Oral,Nausea,photosensitivity,Chelates with divalent cations (antacids Ca2+ Fe2+) reducing absorption May enhance effects of warfarin Associated with photosensitivity and tendon rupture.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information (Arthropathy risk in animals),Prescription
Lomustine,Alkylating Agent,Brain tumors,Capsule,40 mg,Oral,Hodgkin's lymphoma,Myelosuppression,Other bone marrow suppressants may have additive effects Can cause delayed myelosuppression and pulmonary fibrosis.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Loperamide,Antidiarrheal,Diarrhea,Tablet,2 mg,Oral,Constipation,dizziness,QT prolongation has been reported with high doses Can cause toxic megacolon in patients with infectious diarrhea.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Lopinavir-Ritonavir,Protease Inhibitor,HIV infection,Tablet,200/50 mg,Oral,Diarrhea,nausea,Induces and inhibits various CYP450 enzymes affecting many drugs Can cause GI intolerance and hepatotoxicity.,Refrigerate,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Loracarbef,Cephalosporin Antibiotic,Bacterial infections,Capsule,200 mg,Oral,Diarrhea,nausea,Probenecid may decrease excretion May cause diarrhea including Clostridium difficile-associated diarrhea.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Loratadine,Antihistamine,Allergic rhinitis,Tablet,10 mg,Oral,urticaria,Headache,No significant drug interactions at recommended doses Rarely may cause headache or somnolence.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Lorazepam,Benzodiazepine,Anxiety disorders,Tablet,1 mg,Oral,insomnia,Sedation,CNS depressants including alcohol and opioids increase sedation risk Abrupt discontinuation can cause withdrawal symptoms.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Losartan,ARB,Hypertension,Tablet,50 mg,Oral,diabetic nephropathy,Hyperkalemia,NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Use in pregnancy can cause injury and death to the developing fetus.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information (ARB risk),Prescription
Lovastatin,Statin,Hyperlipidemia,Tablet,20 mg,Oral,Headache,myalgia,Strong CYP3A4 inhibitors (eg itraconazole) can significantly increase levels and risk of myopathy Can cause myopathy and rhabdomyolysis.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Luliconazole,Antifungal,Fungal skin infections,Cream,1%,Topical,Skin irritation,burning,No significant drug interactions For topical use only not for ophthalmic use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Lumefantrine,Antimalarial,Malaria (in combination),Tablet,20 mg,Oral,Headache,dizziness,CYP3A4 inhibitors may increase levels and drugs that prolong QT interval are contraindicated Can cause QT prolongation and must be taken with food for absorption.,Room Temperature,Animal studies have demonstrated safety,Not well studied; use only if benefit justifies risk,Prescription
Lurasidone,Atypical Antipsychotic,Schizophrenia,Tablet,40 mg,Oral,bipolar depression,Somnolence,Strong CYP3A4 inhibitors and inducers are contraindicated Can cause somnolence and akathisia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Macitentan,Endothelin Receptor Antagonist,Pulmonary arterial hypertension (PAH),Tablet,10 mg,Oral,Anemia,nasopharyngitis,Strong CYP3A4 inducers may decrease efficacy Contraindicated in pregnancy due to fetal toxicity.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Magaldrate,Antacid,Dyspepsia,Suspension,480 mg/5 mL,Oral,GERD,Diarrhea,Can decrease the absorption of many other drugs administer other drugs 2 hours before or after Can cause diarrhea or constipation.,Room Temperature,Animal studies have demonstrated safety,Generally considered safe in pregnancy,No prescription required
Magnesium Hydroxide,Antacid / Laxative,Constipation,Suspension,400 mg/5 mL,Oral,dyspepsia,Diarrhea,Can decrease the absorption of many other drugs Can cause diarrhea and abdominal cramping.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Mannitol,Osmotic Diuretic,Reduced intracranial/intraocular pressure,Solution,25%,Intravenous,edema,Fluid and electrolyte imbalance,Other diuretics may have additive effects Can cause fluid and electrolyte imbalances and pulmonary congestion.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Maprotiline,Tetracyclic Antidepressant,Depression,Tablet,50 mg,Oral,Sedation,dizziness,MAOIs can cause serotonin syndrome and hyperpyrexia Can lower seizure threshold.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Maraviroc,CCR5 Antagonist,HIV infection,Tablet,150 mg,Oral,Cough,fever,Strong CYP3A4 inhibitors or inducers require dose adjustment Can cause hepatotoxicity and orthostatic hypotension.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Mebendazole,Anthelmintic,Parasitic worm infections,Tablet,100 mg,Oral,Abdominal pain,diarrhea,Carbamazepine and phenytoin decrease mebendazole levels Can cause transaminase elevation and neutropenia.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Mecasermin,Recombinant Human IGF-1,Growth failure,Solution,10 mg/mL,Subcutaneous,Hypoglycemia,injection site reactions,Insulin and other hypoglycemic agents may increase risk Can cause hypoglycemia and require consumption of a meal or snack after administration.,Refrigerate Do Not Freeze,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Meclizine,Antihistamine,Vertigo,Tablet,25 mg,Oral,motion sickness,Sedation,CNS depressants may enhance sedative effects May cause drowsiness and impair mental and physical abilities.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Medroxyprogesterone,Progestin,Contraception,Tablet,10 mg,Oral,abnormal uterine bleeding,Weight gain,Aminoglutethimide may decrease levels Can cause thromboembolic disorders and loss of bone mineral density.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Mefenamic Acid,NSAID,Pain (including menstrual),Capsule,250 mg,Oral,Dyspepsia,diarrhea,ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (NSAID risk),Prescription
Mefloquine,Antimalarial,Malaria prevention and treatment,Tablet,250 mg,Oral,Dizziness,nausea,Beta-blockers and other QT-prolonging agents may have additive effects Can cause severe neuropsychiatric reactions and vertigo.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Megestrol,Progestin,Appetite stimulant (cachexia),Tablet,40 mg,Oral,breast cancer,Thromboembolism,Can increase the effects of warfarin Can cause thromboembolic phenomena and adrenal suppression.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Meloxicam,NSAID,Osteoarthritis,Tablet,7.5 mg,Oral,rheumatoid arthritis,GI upset,ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (NSAID risk),Prescription
Melphalan,Alkylating Agent,Multiple myeloma,Tablet,2 mg,Oral,other cancers,Myelosuppression,Other bone marrow suppressants may have additive effects Can cause severe myelosuppression and secondary malignancies.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Memantine,NMDA Receptor Antagonist,Alzheimer's disease,Tablet,10 mg,Oral,Dizziness,confusion,Drugs that make urine alkaline (eg carbonic anhydrase inhibitors) may decrease excretion Generally well-tolerated with dizziness being the most common side effect.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Meperidine,Opioid Agonist,Pain,Tablet,50 mg,Oral,Sedation,nausea,MAOIs can cause serotonin syndrome and hyperpyrexia Life-threatening respiratory depression may occur.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Opioid risk),Prescription
Mercaptopurine,Antimetabolite,Leukemia,Tablet,50 mg,Oral,Myelosuppression,nausea,Allopurinol inhibits xanthine oxidase increasing levels of active metabolites leading to severe myelosuppression Myelosuppression is dose-related and requires frequent CBC monitoring.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Meropenem,Carbapenem Antibiotic,Serious bacterial infections,Powder for Injection,1 g,Intravenous,Diarrhea,nausea,Valproic acid levels may be significantly reduced Can cause seizures and hypersensitivity reactions.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Mesalamine,5-ASA Derivative,Ulcerative colitis,Tablet (DR),400 mg,Oral,Headache,nausea,No significant drug interactions Can cause renal impairment and acute intolerance syndrome.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Mesna,Uroprotectant,Prevention of hemorrhagic cystitis,Tablet,400 mg,Oral,Nausea,vomiting,No significant drug interactions Used to prevent hemorrhagic cystitis caused by ifosfamide.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Metaxalone,Skeletal Muscle Relaxant,Muscle spasms,Tablet,800 mg,Oral,Drowsiness,dizziness,CNS depressants may enhance sedative effects Can cause hemolytic anemia in patients with G6PD deficiency.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Metformin,Biguanide,Type 2 diabetes,Tablet,500 mg,Oral,Diarrhea,nausea,Alcohol and contrast dye can increase risk of lactic acidosis Can cause lactic acidosis a rare but serious metabolic complication.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Methadone,Opioid Agonist,Pain management,Tablet,5 mg,Oral,opioid use disorder,Constipation,CYP450 inducers or inhibitors can significantly alter levels Can cause QT prolongation and life-threatening respiratory depression.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Opioid risk),Prescription
Methimazole,Antithyroid Agent,Hyperthyroidism,Tablet,10 mg,Oral,Rash,arthralgia,Other bone marrow suppressants may increase risk of agranulocytosis Can cause agranulocytosis and hepatotoxicity.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Methocarbamol,Skeletal Muscle Relaxant,Muscle spasms,Tablet,750 mg,Oral,Drowsiness,dizziness,CNS depressants may enhance sedative effects Can cause discoloration of urine.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Methotrexate,Antimetabolite,Rheumatoid arthritis,Tablet,2.5 mg,Oral,certain cancers,Myelosuppression,NSAIDs and probenecid can decrease renal excretion and increase levels Can cause myelosuppression and hepatotoxicity.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Methoxsalen,Psoralen,Psoriasis,Tablet,10 mg,Oral,vitiligo (with UVA),Nausea,Many drugs are photosensitizing (eg tetracyclines) Can cause severe phototoxic reactions and increased risk of skin cancer.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Methylcellulose,Bulk-Forming Laxative,Constipation,Tablet,500 mg,Oral,Bloating,flatulence,Can decrease the absorption of other drugs administer other drugs at least 1 hour before or after Can cause esophageal obstruction if not taken with enough water.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Methyldopa,Centrally Acting Alpha-2 Agonist,Hypertension,Tablet,250 mg,Oral,Sedation,dizziness,Lithium may cause increased lithium toxicity Can cause hemolytic anemia and positive Coombs test.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Methylergonovine,Ergot Alkaloid,Prevent/treat postpartum hemorrhage,Tablet,0.2 mg,Oral,Nausea,vomiting,Strong CYP3A4 inhibitors are contraindicated due to risk of ergotism Contraindicated in hypertension and coronary artery disease.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Methylnaltrexone,Peripheral Opioid Receptor Antagonist,Opioid-induced constipation,Tablet,12 mg,Subcutaneous,Abdominal pain,diarrhea,No significant drug interactions Can cause abdominal pain and diarrhea.,Refrigerate,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Methylphenidate,CNS Stimulant,ADHD,Tablet (ER),18 mg,Oral,narcolepsy,Insomnia,MAOIs are contraindicated due to risk of hypertensive crisis May exacerbate pre-existing psychosis and cause peripheral vasculopathy.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Methylprednisolone,Corticosteroid,Inflammatory conditions,Tablet,4 mg,Oral,immunosuppression,Hyperglycemia,CYP3A4 inducers (eg phenytoin) may decrease efficacy and inhibitors may increase effects Can cause hyperglycemia and adrenal suppression with prolonged use.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Metoclopramide,Dopamine Antagonist,Gastroparesis,Tablet,10 mg,Oral,nausea/vomiting,Sedation,CNS depressants may enhance sedative effects Can cause extrapyramidal symptoms and tardive dyskinesia.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Metolazone,Thiazide-like Diuretic,Hypertension,Tablet,5 mg,Oral,edema,Hypokalemia,Other antihypertensive drugs can have additive effects Lithium levels may be increased Can cause profound diuresis and electrolyte depletion.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information (Thiazide-like risk),Prescription
Metoprolol,Beta-Blocker,Hypertension,Tablet,50 mg,Oral,angina,heart failure,Other drugs that lower heart rate or blood pressure can have additive effects Abrupt withdrawal may exacerbate angina pectoris or cause myocardial infarction.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information (Beta-blocker risk),Prescription
Metronidazole,Nitroimidazole Antibiotic,Anaerobic bacterial infections,Tablet,500 mg,Oral,protozoal infections,Metallic taste,Disulfiram-like reaction can occur with alcohol Can cause peripheral neuropathy and seizures with prolonged use.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Miconazole,Antifungal,Fungal skin infections,Cream,2%,Topical,vaginal yeast infections,Skin irritation,Warfarin metabolism is inhibited increasing INR For topical use only not for ophthalmic use.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,No prescription required
Midazolam,Benzodiazepine,Sedation,Syrup,1 mg/mL,Oral,anesthesia,anxiolysis,CNS depressants including alcohol and opioids increase sedation risk Can cause profound respiratory depression and hypotension.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Midodrine,Alpha-1 Agonist,Orthostatic hypotension,Tablet,5 mg,Oral,Supine hypertension,paresthesia,Other vasoconstrictors can have additive effects Can cause supine hypertension and bradycardia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Miglitol,Alpha-Glucosidase Inhibitor,Type 2 diabetes,Tablet,25 mg,Oral,Flatulence,diarrhea,Can reduce the bioavailability of digoxin and propranolol Can cause flatulence diarrhea and abdominal pain.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Milrinone,Phosphodiesterase Inhibitor,Heart failure (short-term),Solution,1 mg/mL,Intravenous,Arrhythmias,hypotension,No significant drug interactions Can cause ventricular arrhythmias and hypotension.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Minocycline,Tetracycline Antibiotic,Bacterial infections,Capsule,100 mg,Oral,acne,Photosensitivity,Antacids and calcium supplements decrease absorption Can cause photosensitivity and vestibular toxicity (dizziness vertigo).,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Tooth discoloration risk),Prescription
Minoxidil,Vasodilator / Hair Growth Stimulant,Hypertension,Solution,5%,Topical,androgenetic alopecia,Fluid retention,Other antihypertensive drugs can have additive effects Can cause pericardial effusion and hypertrichosis.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required/Prescription
Mirabegron,Beta-3 Adrenergic Agonist,Overactive bladder,Tablet,25 mg,Oral,Hypertension,headache,Strong CYP2D6 inhibitors may increase levels Can increase blood pressure and cause urinary retention.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Mirtazapine,Tetracyclic Antidepressant,Depression,Tablet,15 mg,Oral,Sedation,weight gain,CNS depressants may enhance sedative effects Can cause significant weight gain and somnolence.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Misoprostol,Prostaglandin Analog,Prevention of NSAID-induced ulcers,Tablet,200 mcg,Oral,Diarrhea,abdominal pain,No significant drug interactions Contraindicated in pregnancy due to abortifacient properties.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Mitomycin,Antitumor Antibiotic,Various cancers,Powder for Injection,5 mg,Intravenous,Myelosuppression,mucositis,Other bone marrow suppressants may have additive effects Can cause severe myelosuppression and hemolytic uremic syndrome.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Mitotane,Adrenolytic Agent,Adrenocortical carcinoma,Tablet,500 mg,Oral,Nausea,vomiting,CYP3A4 inducers may decrease efficacy Can cause adrenal insufficiency and neurotoxicity.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Mitoxantrone,Anthracenedione Antibiotic,Multiple sclerosis,Solution,2 mg/mL,Intravenous,certain cancers,Myelosuppression,Other cardiotoxic drugs increase risk Can cause severe myelosuppression and cardiotoxicity.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Modafinil,CNS Stimulant,Narcolepsy,Tablet,100 mg,Oral,sleep apnea,shift work disorder,Induces CYP3A4 and inhibits CYP2C19 affecting many drugs Can cause serious skin reactions and psychiatric symptoms.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Mometasone,Topical / Inhaled Corticosteroid,Inflammatory skin conditions,Cream,0.10%,Topical,asthma,Skin atrophy,Strong CYP3A4 inhibitors may increase systemic exposure Systemic absorption can occur with extensive use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Montelukast,Leukotriene Receptor Antagonist,Asthma,Tablet,10 mg,Oral,allergic rhinitis,Headache,Phenobarbital may decrease levels Can cause neuropsychiatric events including agitation and depression.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Morphine,Opioid Agonist,Pain,Tablet (ER),15 mg,Oral,Constipation,nausea,CNS depressants including alcohol and benzodiazepines increase sedation risk Life-threatening respiratory depression may occur.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Opioid risk),Prescription
Moxifloxacin,Fluoroquinolone Antibiotic,Bacterial infections,Tablet,400 mg,Oral,Nausea,diarrhea,Drugs that prolong the QT interval may have additive effects Associated with tendonitis and tendon rupture and may exacerbate myasthenia gravis.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information (Arthropathy risk in animals),Prescription
Mupirocin,Antibiotic,Topical skin infections (impetigo),Ointment,2%,Topical,Burning,itching,No significant drug interactions For topical use only not for ophthalmic use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Mycophenolate Mofetil,Immunosuppressant,Organ transplant rejection,Tablet,500 mg,Oral,autoimmune disorders,Diarrhea,Antacids and cholestyramine can decrease absorption Can cause severe myelosuppression and increased risk of infections.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Nabumetone,NSAID,Osteoarthritis,Tablet,750 mg,Oral,rheumatoid arthritis,GI upset,ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (NSAID risk),Prescription
Nadolol,Beta-Blocker,Hypertension,Tablet,40 mg,Oral,angina,Bradycardia,Other drugs that lower heart rate or blood pressure can have additive effects Abrupt withdrawal may exacerbate angina pectoris or cause myocardial infarction.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information (Beta-blocker risk),Prescription
Nafcillin,Penicillin Antibiotic,Bacterial infections,Powder for Injection,1 g,Intravenous,Diarrhea,nausea,Warfarin metabolism is increased decreasing INR Can cause vein irritation and phlebitis with IV administration.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Nalbuphine,Opioid Agonist-Antagonist,Pain,Solution,10 mg/mL,Intramuscular,Sedation,dizziness,CNS depressants may enhance sedative effects Can cause withdrawal in patients dependent on other opioids.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information (Opioid risk),Prescription
Naloxone,Opioid Antagonist,Opioid overdose,Solution,0.4 mg/mL,Intramuscular,Precipitated withdrawal,hypertension,No significant drug interactions Can precipitate acute withdrawal in patients dependent on opioids.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Naltrexone,Opioid Antagonist,Alcohol use disorder,Tablet,50 mg,Oral,opioid use disorder,Nausea,No significant drug interactions Can precipitate acute withdrawal in patients dependent on opioids.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Naproxen,NSAID,Pain,Tablet,500 mg,Oral,inflammation,dysmenorrhea,ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (NSAID risk),No prescription required/Prescription
Naratriptan,5-HT1 Agonist,Migraine attacks,Tablet,2.5 mg,Oral,Dizziness,drowsiness,Other 5-HT1 agonists can have additive effects Contraindicated in ischemic heart disease and uncontrolled hypertension.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Nateglinide,Meglitinide,Type 2 diabetes,Tablet,120 mg,Oral,Hypoglycemia,weight gain,Drugs that increase hypoglycemia risk (eg beta-blockers) Can cause hypoglycemia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Nebivolol,Beta-Blocker,Hypertension,Tablet,5 mg,Oral,Bradycardia,fatigue,Other drugs that lower heart rate or blood pressure can have additive effects Can cause bradycardia and heart failure.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information (Beta-blocker risk),Prescription
Nefazodone,Serotonin Antagonist and Reuptake Inhibitor (SARI),Depression,Tablet,100 mg,Oral,Sedation,dry mouth,MAOIs can cause serotonin syndrome and CYP3A4 inhibitors may increase levels Can cause rare but serious hepatotoxicity.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Nelfinavir,Protease Inhibitor,HIV infection,Tablet,625 mg,Oral,Diarrhea,nausea,Induces and inhibits various CYP450 enzymes affecting many drugs Can cause diarrhea and rash.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Neomycin,Aminoglycoside Antibiotic,Hepatic encephalopathy,Tablet,500 mg,Oral,topical infections,Nephrotoxicity,Other nephrotoxic or ototoxic drugs increase risk of toxicity Can cause ototoxicity and nephrotoxicity with systemic use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information (Aminoglycoside risk of ototoxicity),Prescription
Neostigmine,Cholinesterase Inhibitor,Myasthenia gravis,Tablet,15 mg,Oral,reversal of neuromuscular blockade,Nausea,Other cholinergic agents can have additive effects Can cause bradycardia and bronchospasm.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Nevirapine,NNRTI,HIV infection,Tablet,200 mg,Oral,Rash,hepatotoxicity,Induces CYP3A4 decreasing levels of many drugs Can cause severe skin reactions and hepatotoxicity.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Niacin,Vitamin B3,Hyperlipidemia,Tablet,500 mg,Oral,niacin deficiency,Flushing,Statins may increase risk of myopathy Can cause profound flushing and hepatotoxicity.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required/Prescription
Niacinamide,Vitamin B3,Niacin deficiency,Tablet,500 mg,Oral,Pruritus,flushing,No significant drug interactions Generally well-tolerated at recommended doses.,Room Temperature,Animal studies have demonstrated safety,Generally considered safe at recommended dietary amounts,No prescription required
Nicardipine,Dihydropyridine CCB,Hypertension,Capsule,30 mg,Oral,angina,Headache,Strong CYP3A4 inhibitors can significantly increase levels Can cause peripheral edema and reflex tachycardia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Nifedipine,Dihydropyridine CCB,Hypertension,Capsule (ER),30 mg,Oral,angina,Peripheral edema,Strong CYP3A4 inhibitors can significantly increase levels Can cause peripheral edema and reflex tachycardia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Nilotinib,Kinase Inhibitor,Chronic myeloid leukemia (CML),Capsule,200 mg,Oral,Myelosuppression,QT prolongation,Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause QT prolongation and sudden death.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Nimodipine,Dihydropyridine CCB,Prevention of vasospasm after subarachnoid hemorrhage,Capsule,30 mg,Oral,Hypotension,headache,Strong CYP3A4 inhibitors can significantly increase levels Must be administered orally via nasogastric tube if patient cannot swallow.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Nisoldipine,Dihydropyridine CCB,Hypertension,Tablet (ER),20 mg,Oral,Headache,peripheral edema,Strong CYP3A4 inhibitors can significantly increase levels Can cause peripheral edema and reflex tachycardia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Nitazoxanide,Antiprotozoal,Diarrhea caused by Cryptosporidium or Giardia,Tablet,500 mg,Oral,Abdominal pain,headache,No significant drug interactions Can cause abdominal pain and diarrhea.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Nitrofurantoin,Antibiotic,Uncomplicated UTIs,Capsule,100 mg,Oral,Nausea,pulmonary fibrosis,Antacids may decrease absorption Can cause pulmonary fibrosis and peripheral neuropathy with long-term use.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Nizatidine,H2 Blocker,Peptic ulcer disease,Capsule,150 mg,Oral,GERD,Headache,No significant drug interactions May cause confusion more commonly in elderly or severely ill patients.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Norepinephrine,Alpha Agonist,Shock,Solution,1 mg/mL,Intravenous,hypotension,Tissue necrosis with extravasation,MAOIs can cause severe hypertension Extravasation can cause tissue necrosis and sloughing.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Norethindrone,Progestin,Contraception,Tablet,0.35 mg,Oral,abnormal uterine bleeding,Breakthrough bleeding,CYP3A4 inducers can decrease efficacy Can cause thromboembolic disorders.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Norgestimate-Ethinyl Estradiol,Progestin + Estrogen,Contraception,Tablet,0.25/0.035 mg,Oral,Nausea,headache,CYP3A4 inducers (eg rifampin) can decrease efficacy and increase breakthrough bleeding Increases risk of thromboembolic disorders and stroke.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Nortriptyline,Tricyclic Antidepressant,Depression,Capsule,25 mg,Oral,Dry mouth,sedation,MAOIs can cause serotonin syndrome and hyperpyrexia Strong anticholinergic effects may occur with other drugs Increased risk of suicide in children and young adults.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Nystatin,Antifungal,Fungal infections (oral,000 unit/mL,100,Suspension,cutaneous),Nausea,No significant drug interactions For topical or oral use only not for systemic use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Oral
Obinutuzumab,Monoclonal Antibody,Chronic lymphocytic leukemia (CLL),Solution,1000 mg/40 mL,Intravenous,Infusion reactions,myelosuppression,Hepatitis B virus reactivation can occur Can cause severe infusion reactions and tumor lysis syndrome.,Refrigerate,Contraindicated (not allowed),No data; potential for B-cell depletion in fetus,Prescription
Ofloxacin,Fluoroquinolone Antibiotic,Bacterial infections,Tablet,400 mg,Oral,Nausea,insomnia,Chelates with divalent cations (antacids Ca2+ Fe2+) reducing absorption May enhance effects of warfarin Associated with tendonitis and tendon rupture.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information (Arthropathy risk in animals),Prescription
Olanzapine,Atypical Antipsychotic,Schizophrenia,Tablet,10 mg,Oral,bipolar disorder,Weight gain,CNS depressants may enhance sedative effects Can cause metabolic changes including weight gain hyperlipidemia and hyperglycemia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Olmesartan,ARB,Hypertension,Tablet,20 mg,Oral,Hyperkalemia,dizziness,NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Use in pregnancy can cause injury and death to the developing fetus.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information (ARB risk),Prescription
Olodaterol,LABA,COPD,Inhaler,2.5 mcg/actuation,Inhalation,Headache,back pain,Other adrenergic drugs can have additive cardiovascular effects Can cause paradoxical bronchospasm and increase the risk of asthma-related death.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Olopatadine,Antihistamine / Mast Cell Stabilizer,Allergic conjunctivitis,Solution,0.20%,Ophthalmic,Headache,dry eyes,No significant drug interactions For ophthalmic use only may cause mild transient burning or stinging.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Omeprazole,Proton Pump Inhibitor,GERD,Capsule (DR),20 mg,Oral,erosive esophagitis,Headache,Can reduce absorption of drugs requiring gastric pH for absorption (eg ketoconazole) May increase risk of Clostridium difficile-associated diarrhea and bone fractures with long-term use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required/Prescription
Ondansetron,5-HT3 Antagonist,Chemotherapy-induced nausea/vomiting,Tablet,8 mg,Oral,Headache,constipation,Drugs that prolong the QT interval may have additive effects Can cause QT prolongation and subsequent arrhythmias.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Orlistat,Lipase Inhibitor,Obesity management,Capsule,60 mg,Oral,Oily spotting,flatus with discharge,Can reduce absorption of fat-soluble vitamins (A D E K) Can cause steatorrhea and fecal incontinence.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Orphenadrine,Skeletal Muscle Relaxant,Muscle spasms,Tablet (ER),100 mg,Oral,Dry mouth,blurred vision,Other anticholinergic drugs can have additive effects Can cause drowsiness and dry mouth.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Oseltamivir,Neuraminidase Inhibitor,Influenza,Capsule,75 mg,Oral,Nausea,vomiting,No significant drug interactions May cause nausea and vomiting and rare neuropsychiatric events.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Oxacillin,Penicillin Antibiotic,Bacterial infections,Capsule,500 mg,Oral,Diarrhea,nausea,Probenecid may decrease excretion Serious and occasionally fatal hypersensitivity reactions have been reported.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Oxaliplatin,Alkylating Agent,Colorectal cancer,Solution,5 mg/mL,Intravenous,Neurotoxicity,nausea,Other nephrotoxic drugs may enhance platinum-induced renal toxicity Can cause peripheral sensory neuropathy and pharyngolaryngeal dysesthesia.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Oxaprozin,NSAID,Osteoarthritis,Tablet,600 mg,Oral,rheumatoid arthritis,GI upset,ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (NSAID risk),Prescription
Oxazepam,Benzodiazepine,Anxiety disorders,Capsule,15 mg,Oral,alcohol withdrawal,Sedation,CNS depressants including alcohol and opioids increase sedation risk Abrupt discontinuation can cause withdrawal symptoms.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Oxcarbazepine,Anticonvulsant,Seizures,Tablet,300 mg,Oral,Dizziness,diplopia,Strong CYP3A4 inducers may decrease levels of active metabolite Can cause hyponatremia and cross-hypersensitivity with carbamazepine.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Oxybutynin,Anticholinergic,Overactive bladder,Tablet,5 mg,Oral,Dry mouth,constipation,Other anticholinergic drugs can have additive effects Can cause blurred vision and urinary retention.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Oxycodone,Opioid Agonist,Pain,Tablet,10 mg,Oral,Constipation,nausea,CNS depressants including alcohol and benzodiazepines increase sedation risk Life-threatening respiratory depression may occur.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Opioid risk),Prescription
Oxymetazoline,Alpha Agonist,Nasal congestion,Spray,0.05%,Nasal,Rebound congestion,burning,MAOIs can cause hypertensive crisis Can cause rebound congestion (rhinitis medicamentosa) with prolonged use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Oxytetracycline,Tetracycline Antibiotic,Bacterial infections,Capsule,250 mg,Oral,Photosensitivity,nausea,Antacids and calcium supplements decrease absorption Can cause photosensitivity and tooth discoloration.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Tooth discoloration risk),Prescription
Paclitaxel,Antimicrotubule Agent,Ovarian cancer,Solution,6 mg/mL,Intravenous,breast cancer,other cancers,Strong CYP3A4 or CYP2C8 inhibitors may increase levels Can cause severe hypersensitivity reactions myelosuppression and peripheral neuropathy.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Palbociclib,CDK4/6 Inhibitor,Breast cancer,Capsule,125 mg,Oral,Myelosuppression,fatigue,Strong CYP3A4 inhibitors may increase levels Can cause severe neutropenia and pulmonary embolism.,Room Temperature,Contraindicated (not allowed),No data; based on mechanism likely D,Prescription
Paliperidone,Atypical Antipsychotic,Schizophrenia,Tablet (ER),3 mg,Oral,Weight gain,tachycardia,Strong CYP3A4 or P-gp inducers may decrease levels Can cause QT prolongation and orthostatic hypotension.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Palonosetron,5-HT3 Antagonist,Chemotherapy-induced nausea/vomiting,Solution,0.25 mg/5 mL,Intravenous,Headache,constipation,No significant drug interactions Generally well-tolerated with constipation being the most common side effect.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Pamidronate,Bisphosphonate,Hypercalcemia of malignancy,Solution,90 mg,Intravenous,bone metastases,Flu-like symptoms,Nephrotoxic drugs may increase risk of renal impairment Can cause renal impairment and hypocalcemia.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Pantoprazole,Proton Pump Inhibitor,GERD,Tablet (DR),40 mg,Oral,erosive esophagitis,Headache,Can reduce absorption of drugs requiring gastric pH for absorption (eg ketoconazole) May increase risk of Clostridium difficile-associated diarrhea and bone fractures with long-term use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Papaverine,Vasodilator,Visceral spasm,Tablet (ER),150 mg,Oral,sometimes erectile dysfunction,Hypotension,No significant drug interactions Can cause hepatic hypersensitivity with elevated LFTs.,Room Temperature,Animal studies have demonstrated safety,No data,Prescription
Paromomycin,Aminoglycoside Antibiotic,Intestinal amebiasis,Tablet,250 mg,Oral,Diarrhea,nausea,Other nephrotoxic or ototoxic drugs increase risk of toxicity Used for intestinal amebiasis not systemic infections.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Paroxetine,SSRI,Depression,Tablet,20 mg,Oral,anxiety disorders,Nausea,MAOIs can cause serotonin syndrome and strong inhibitors of CYP2D6 may increase levels May increase risk of bleeding especially with NSAIDs or warfarin.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information (Cardiac risk),Prescription
Pazopanib,Kinase Inhibitor,Renal cell carcinoma,Tablet,200 mg,Oral,soft tissue sarcoma,Diarrhea,Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause hepatotoxicity and QT prolongation.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Pegfilgrastim,G-CSF Analog,Chemotherapy-induced neutropenia,Solution,6 mg/0.6 mL,Subcutaneous,Bone pain,headache,No significant drug interactions Can cause bone pain and splenic rupture.,Refrigerate,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Peginterferon Alfa-2a,Immunomodulator,Hepatitis B/C,Solution,180 mcg/1 mL,Subcutaneous,Psychiatric effects,flu-like symptoms,Theophylline clearance may be decreased Can cause severe psychiatric effects myelosuppression and autoimmunity.,Refrigerate,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Pegloticase,Urate Oxidase Enzyme,Refractory gout,Solution,8 mg/1 mL,Intravenous,Infusion reactions,gout flares,No significant drug interactions Can cause severe infusion reactions and anaphylaxis.,Refrigerate,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Pembrolizumab,PD-1 Inhibitor,Various cancers,Solution,100 mg/4 mL,Intravenous,Fatigue,rash,No significant drug interactions Can cause immune-mediated adverse reactions affecting any organ system.,Refrigerate,Animal studies have demonstrated safety,No data; potential for immune-mediated disorders in fetus,Prescription
Pemirolast,Mast Cell Stabilizer,Allergic conjunctivitis,Solution,0.10%,Ophthalmic,Headache,dry eyes,No significant drug interactions For ophthalmic use only may cause headache or rhinitis.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Penciclovir,Antiviral,Herpes labialis (cold sores),Cream,1%,Topical,Application site reaction,headache,No significant drug interactions For topical use only not for ophthalmic or oral use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Penicillin G,Penicillin Antibiotic,Bacterial infections,Powder for Injection,5 million unit,Intravenous,Diarrhea,nausea,Probenecid may decrease excretion Serious and occasionally fatal hypersensitivity reactions have been reported.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Penicillin V,Penicillin Antibiotic,Bacterial infections,Tablet,500 mg,Oral,Diarrhea,nausea,Probenecid may decrease excretion Serious and occasionally fatal hypersensitivity reactions have been reported.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Pentamidine,Antiprotozoal,Pneumocystis jirovecii pneumonia (PCP),Powder for Injection,300 mg,Inhalation,Hypotension,hypoglycemia,Other nephrotoxic drugs increase risk of toxicity Can cause severe hypotension hypoglycemia and nephrotoxicity.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Pentazocine,Opioid Agonist-Antagonist,Pain,Tablet,50 mg,Oral,Dizziness,sedation,CNS depressants may enhance sedative effects Can cause withdrawal in patients dependent on other opioids.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information (Opioid risk),Prescription
Pentobarbital,Barbiturate,Sedation,Capsule,100 mg,Oral,insomnia,seizures,CNS depressants may enhance sedative effects Can cause respiratory depression and dependence.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Pentosan,Urinary Analgesic,Interstitial cystitis,Capsule,100 mg,Oral,Alopecia,nausea,Other anticoagulants may increase bleeding risk Can cause bleeding and alopecia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Pentoxifylline,Xanthine Derivative,Intermittent claudication,Tablet (ER),400 mg,Oral,Nausea,dyspepsia,Antihypertensive drugs may have additive effects Can cause nausea and dizziness.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Perampanel,AMPA Receptor Antagonist,Seizures,Tablet,4 mg,Oral,Dizziness,somnolence,Strong CYP3A4 inducers may decrease efficacy Can cause serious neuropsychiatric events including aggression and hostility.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Perindopril,ACE Inhibitor,Hypertension,Tablet,4 mg,Oral,heart failure,Cough,NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Risk of angioedema can occur at any time discontinue immediately.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information (ACE Inhibitor risk),Prescription
Permethrin,Scabicidal / Pediculicidal,Scabies,Cream,5%,Topical,lice,Pruritus,No significant drug interactions For topical use only if ingestion occurs can cause CNS effects.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Perphenazine,Typical Antipsychotic,Psychotic disorders,Tablet,4 mg,Oral,Extrapyramidal symptoms,sedation,CNS depressants may enhance sedative effects Can cause extrapyramidal symptoms and neuroleptic malignant syndrome.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Phenazopyridine,Urinary Analgesic,Urinary tract pain,Tablet,200 mg,Oral,GI upset,headache,No significant drug interactions Can cause red-orange discoloration of urine and may stain clothing.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Phenelzine,MAOI,Depression,Tablet,15 mg,Oral,Orthostatic hypotension,dry mouth,Tyramine-containing foods and serotonergic drugs can cause hypertensive crisis and serotonin syndrome Requires strict dietary restrictions to prevent hypertensive crisis.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Phenobarbital,Barbiturate,Seizures,Tablet,30 mg,Oral,sedation,Sedation,Induces CYP450 enzymes reducing levels of many drugs (eg oral contraceptives warfarin) Can cause respiratory depression and dependence.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Phentermine,Sympathomimetic Amine,Obesity (short-term),Tablet,37.5 mg,Oral,Insomnia,dry mouth,MAOIs can cause hypertensive crisis High potential for abuse and dependence.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Phenytoin,Anticonvulsant,Seizures,Capsule,100 mg,Oral,Gingival hyperplasia,nystagmus,Many drugs can increase or decrease phenytoin levels Can cause life-threatening dermatologic reactions like Stevens-Johnson syndrome.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Fetal hydantoin syndrome risk),Prescription
Pilocarpine,Cholinergic,Glaucoma,Tablet,5 mg,Oral,xerostomia,Sweating,Other cholinergic agents can have additive effects Can cause blurred vision and sweating.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Pimavanserin,Serotonin Inverse Agonist,Parkinson's disease psychosis,Capsule,34 mg,Oral,QT prolongation,peripheral edema,Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can prolong the QT interval.,Room Temperature,Animal studies have demonstrated safety,No data,Prescription
Pimecrolimus,Calcineurin Inhibitor,Atopic dermatitis,Cream,1%,Topical,Burning,headache,No significant drug interactions May increase risk of skin malignancies and lymphomas.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Pimozide,Typical Antipsychotic,Tourette's syndrome,Tablet,2 mg,Oral,Extrapyramidal symptoms,sedation,Strong CYP3A4 inhibitors are contraindicated due to risk of QT prolongation Can cause QT prolongation and extrapyramidal symptoms.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Pindolol,Beta-Blocker,Hypertension,Tablet,5 mg,Oral,Bradycardia,fatigue,Other drugs that lower heart rate or blood pressure can have additive effects Abrupt withdrawal may exacerbate angina pectoris or cause myocardial infarction.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information (Beta-blocker risk),Prescription
Pioglitazone,Thiazolidinedione,Type 2 diabetes,Tablet,30 mg,Oral,Weight gain,edema,Strong CYP2C8 inhibitors may increase levels Can cause or exacerbate congestive heart failure and bladder cancer.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Piperacillin-Tazobactam,Penicillin Antibiotic + Beta-Lactamase Inhibitor,Serious bacterial infections,Powder for Injection,3.375 g,Intravenous,Diarrhea,nausea,Probenecid may decrease excretion May cause diarrhea including Clostridium difficile-associated diarrhea.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Pirbuterol,SABA,Asthma,Inhaler,0.4 mg/actuation,Inhalation,bronchospasm,Tachycardia,Beta-blockers may antagonize the effects Can cause paradoxical bronchospasm and cardiovascular effects.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Piroxicam,NSAID,Osteoarthritis,Capsule,20 mg,Oral,rheumatoid arthritis,GI upset,ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (NSAID risk),Prescription
Pitavastatin,Statin,Hyperlipidemia,Tablet,2 mg,Oral,Headache,myalgia,Cyclosporine may increase levels Can cause myopathy and rhabdomyolysis.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Pramipexole,Dopamine Agonist,Parkinson's disease,Tablet,0.25 mg,Oral,restless legs syndrome,Nausea,Other CNS depressants may enhance sedative effects Can cause somnolence and impulse control disorders.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Pramlintide,Amylin Analog,Type 1 & 2 diabetes (adjunct),Solution,0.6 mg/0.1 mL,Subcutaneous,Nausea,hypoglycemia,Other drugs that affect GI motility may have additive effects Can cause severe hypoglycemia especially when used with insulin.,Refrigerate,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Prasugrel,Antiplatelet,Acute coronary syndrome,Tablet,10 mg,Oral,Bleeding,headache,Other drugs that affect hemostasis increase bleeding risk Contraindicated in patients with history of stroke or TIA.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Pravastatin,Statin,Hyperlipidemia,Tablet,40 mg,Oral,Headache,myalgia,Not significantly metabolized by CYP450 enzymes fewer interactions Can cause myopathy and rhabdomyolysis.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Praziquantel,Anthelmintic,Schistosomiasis,Tablet,600 mg,Oral,other fluke infections,Dizziness,CYP450 inducers like carbamazepine can decrease levels Can cause abdominal discomfort and dizziness.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Prazosin,Alpha-1 Blocker,Hypertension,Capsule,1 mg,Oral,BPH,Dizziness,Other antihypertensive drugs can have additive effects Can cause marked first-dose hypotension and syncope.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Prednisolone,Corticosteroid,Inflammatory conditions,Tablet,5 mg,Oral,immunosuppression,Hyperglycemia,CYP3A4 inducers (eg phenytoin) may decrease efficacy and inhibitors may increase effects Can cause hyperglycemia and adrenal suppression with prolonged use.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Prednisone,Corticosteroid,Inflammatory conditions,Tablet,20 mg,Oral,immunosuppression,Hyperglycemia,CYP3A4 inducers (eg phenytoin) may decrease efficacy and inhibitors may increase effects Can cause hyperglycemia and adrenal suppression with prolonged use.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Pregabalin,Anticonvulsant,Neuropathic pain,Capsule,75 mg,Oral,seizures,Dizziness,CNS depressants may enhance sedative effects Can cause angioedema and withdrawal symptoms upon discontinuation.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Primaquine,Antimalarial,Malaria (radical cure for P. vivax/ovale),Tablet,26.3 mg,Oral,GI upset,hemolytic anemia in G6PD deficiency,Other drugs that cause hemolysis or depress myeloid function can have additive effects Can cause hemolytic anemia in patients with G6PD deficiency.,Room Temperature,Contraindicated (not allowed),Not recommended; can cause hemolysis in G6PD deficiency,Prescription
Primidone,Anticonvulsant,Seizures,Tablet,250 mg,Oral,Sedation,ataxia,CNS depressants may enhance sedative effects Can cause sedation and megaloblastic anemia.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Probenecid,Uricosuric,Gout,Tablet,500 mg,Oral,Hyperuricemia,headache,Increases levels of many drugs by inhibiting their renal secretion (eg penicillins methotrexate) Can cause GI upset and nephrotic syndrome.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Procainamide,Antiarrhythmic (Class Ia),Ventricular arrhythmias,Tablet (CR),500 mg,Oral,Lupus-like syndrome,nausea,Other drugs that prolong the QT interval increase risk of torsades de pointes Can cause lupus-like syndrome and blood dyscrasias.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Prochlorperazine,Typical Antipsychotic / Antiemetic,Psychotic disorders,Tablet,10 mg,Oral,nausea/vomiting,Extrapyramidal symptoms,CNS depressants may enhance sedative effects Can cause extrapyramidal symptoms and neuroleptic malignant syndrome.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Progesterone,Progestin,Hormone replacement,Capsule,100 mg,Oral,abnormal uterine bleeding,Drowsiness,CYP3A4 inducers can decrease efficacy Can cause thromboembolic disorders.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Promethazine,Antihistamine / Antiemetic,Allergic reactions,Tablet,25 mg,Oral,nausea/vomiting,Sedation,CNS depressants may enhance sedative effects Can cause respiratory depression in children and extrapyramidal symptoms.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Propafenone,Antiarrhythmic (Class Ic),Ventricular arrhythmias,Tablet,150 mg,Oral,atrial fibrillation,Dizziness,Strong CYP2D6 inhibitors may increase levels Can cause new or worsened arrhythmias and bronchospasm in patients with asthma.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Propantheline,Anticholinergic,Peptic ulcer disease,Tablet,15 mg,Oral,GI spasms,Dry mouth,Other anticholinergic drugs can have additive effects Contraindicated in patients with glaucoma or severe ulcerative colitis.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Propofol,General Anesthetic,Induction/maintenance of anesthesia,Emulsion,10 mg/mL,Intravenous,Respiratory depression,hypotension,CNS depressants may enhance sedative effects Can cause profound respiratory depression and hypotension.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Propranolol,Beta-Blocker,Hypertension,Tablet,20 mg,Oral,angina,migraine prevention,Other drugs that lower heart rate or blood pressure can have additive effects Abrupt withdrawal may exacerbate angina pectoris or cause myocardial infarction.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information (Beta-blocker risk),Prescription
Propylthiouracil,Antithyroid Agent,Hyperthyroidism,Tablet,50 mg,Oral,Rash,arthralgia,Other bone marrow suppressants may increase risk of agranulocytosis Can cause agranulocytosis and hepatotoxicity.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Protamine,Antidote,Reversal of heparin anticoagulation,Solution,10 mg/mL,Intravenous,Hypotension,bradycardia,No significant drug interactions Can cause severe hypotension and anaphylaxis.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Pseudoephedrine,Sympathomimetic,Nasal congestion,Tablet,60 mg,Oral,Insomnia,dizziness,MAOIs can cause hypertensive crisis Can cause insomnia and tachycardia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Pyrazinamide,Antimycobacterial,Tuberculosis,Tablet,500 mg,Oral,Hepatotoxicity,hyperuricemia,May increase uric acid levels Can cause hepatotoxicity and hyperuricemia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Pyridostigmine,Cholinesterase Inhibitor,Myasthenia gravis,Tablet,60 mg,Oral,Nausea,salivation,Other cholinergic agents can have additive effects Can cause bradycardia and bronchospasm.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Pyrimethamine,Antimalarial / Antiprotozoal,Malaria,Tablet,25 mg,Oral,toxoplasmosis,Myelosuppression,Other drugs that cause folate deficiency can have additive effects Can cause megaloblastic anemia and blood dyscrasias.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Quetiapine,Atypical Antipsychotic,Schizophrenia,Tablet,100 mg,Oral,bipolar disorder,Somnolence,Strong CYP3A4 inhibitors may increase levels Can cause sedation cataracts and metabolic changes.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Quinapril,ACE Inhibitor,Hypertension,Tablet,20 mg,Oral,heart failure,Cough,NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Risk of angioedema can occur at any time discontinue immediately.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information (ACE Inhibitor risk),Prescription
Quinidine,Antiarrhythmic (Class Ia),Atrial fibrillation/flutter,Tablet (ER),324 mg,Oral,GI upset,cinchonism,Inhibits CYP2D6 and CYP3A4 increasing levels of many drugs Can cause cinchonism and thrombocytopenia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Quinine,Antimalarial,Malaria (chloroquine-resistant),Tablet,324 mg,Oral,Cinchonism (tinnitus,headache),Other drugs that prolong the QT interval increase risk of torsades de pointes Can cause cinchonism and blackwater fever.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Rabeprazole,Proton Pump Inhibitor,GERD,Tablet (DR),20 mg,Oral,erosive esophagitis,Headache,Can reduce absorption of drugs requiring gastric pH for absorption (eg ketoconazole) May increase risk of Clostridium difficile-associated diarrhea and bone fractures with long-term use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Raloxifene,SERM,Osteoporosis prevention/treatment in postmenopausal women,Tablet,60 mg,Oral,Hot flashes,leg cramps,Cholestyramine may decrease absorption Increases risk of thromboembolic events and fatal stroke.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Raltegravir,Integrase Strand Transfer Inhibitor,HIV infection,Tablet,400 mg,Oral,Headache,insomnia,Strong UGT1A1 inducers may decrease levels Can cause severe and potentially fatal skin reactions.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Ramipril,ACE Inhibitor,Hypertension,Capsule,5 mg,Oral,heart failure,diabetic nephropathy,NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Risk of angioedema can occur at any time discontinue immediately.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information (ACE Inhibitor risk),Prescription
Ranitidine,H2 Blocker,Peptic ulcer disease,Tablet,150 mg,Oral,GERD,Headache,No significant drug interactions May cause confusion more commonly in elderly or severely ill patients.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Rasagiline,MAOI,Parkinson's disease,Tablet,1 mg,Oral,Nausea,dizziness,Other MAOIs and sympathomimetics can cause hypertensive crisis Can cause hypertensive crisis if tyramine-rich foods are consumed.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Rasburicase,Urate Oxidase Enzyme,Tumor lysis syndrome,Powder for Injection,1.5 mg,Intravenous,Hyperensitivity,hemolysis,No significant drug interactions Can cause severe hypersensitivity reactions and hemolysis in patients with G6PD deficiency.,Refrigerate,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Regorafenib,Kinase Inhibitor,Colorectal cancer,Tablet,40 mg,Oral,GIST,Fatigue,Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause severe hepatotoxicity and hemorrhage.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Remdesivir,Antiviral,COVID-19,Powder for Injection,100 mg,Intravenous,Nausea,elevated LFTs,No significant drug interactions Not recommended in patients with eGFR < 30 mL/min.,Refrigerate,Animal studies have demonstrated safety,No data; use only if potential benefit justifies risk,Prescription
Reserpine,Antiaderenergic,Hypertension,Tablet,0.1 mg,Oral,Depression,nasal congestion,MAOIs can cause excitability and hypertension Can cause depression and suicidal ideation.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Retapamulin,Antibiotic,Impetigo,Ointment,1%,Topical,Application site irritation,pruritus,No significant drug interactions For topical use only not for oral or ophthalmic use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Ribavirin,Antiviral,Hepatitis C,Capsule,200 mg,Oral,RSV infection,Hemolytic anemia,Interferon alfa may increase toxicity Highly teratogenic and embryocidal requires strict pregnancy prevention.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Rifabutin,Antimycobacterial,Mycobacterium avium complex (MAC) prophylaxis,Capsule,150 mg,Oral,Neutropenia,uveitis,Induces CYP3A4 decreasing levels of many drugs Can cause uveitis and neutropenia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Rifampin,Antimycobacterial,Tuberculosis,Capsule,300 mg,Oral,Hepatotoxicity,orange discoloration of bodily fluids,A strong inducer of CYP450 enzymes decreasing levels of many drugs Can cause hepatotoxicity and orange discoloration of bodily fluids.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Rifapentine,Antimycobacterial,Tuberculosis,Tablet,150 mg,Oral,Hyperuricemia,pyuria,Induces CYP3A4 and CYP2C8/9 decreasing levels of many drugs Can cause hepatotoxicity and hyperuricemia.,Room Temperature,Animal studies have demonstrated safety,No data; likely C,Prescription
Rifaximin,Antibiotic,Traveler's diarrhea,Tablet,200 mg,Oral,hepatic encephalopathy,Nausea,No significant drug interactions For travelers' diarrhea and hepatic encephalopathy not systemic infections.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Rilpivirine,NNRTI,HIV infection,Tablet,25 mg,Oral,Depression,insomnia,Proton pump inhibitors are contraindicated as they significantly decrease levels Can cause depressive disorders and hepatotoxicity.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Riluzole,Glutamate Inhibitor,Amyotrophic lateral sclerosis (ALS),Tablet,50 mg,Oral,Nausea,dizziness,Strong CYP1A2 inhibitors may increase levels Can cause elevated liver enzymes and neutropenia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Rimantadine,Antiviral,Influenza A,Tablet,100 mg,Oral,Insomnia,nausea,Acetaminophen and aspirin may decrease rimantadine levels Can cause CNS side effects like insomnia and dizziness.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Risedronate,Bisphosphonate,Osteoporosis,Tablet,35 mg,Oral,Paget's disease,GI upset,Calcium supplements and other oral medications can interfere with absorption Risk of esophageal irritation and osteonecrosis of the jaw.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Risperidone,Atypical Antipsychotic,Schizophrenia,Tablet,1 mg,Oral,bipolar disorder,Weight gain,Strong CYP2D6 inhibitors may increase levels Can cause hyperprolactinemia and metabolic changes.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Ritonavir,Protease Inhibitor,HIV infection (often as booster),Tablet,100 mg,Oral,Nausea,diarrhea,A strong inhibitor of CYP3A4 affecting many drugs Can cause GI intolerance hepatotoxicity and pancreatitis.,Refrigerate,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Rivaroxaban,Direct Oral Anticoagulant (Factor Xa Inhibitor),Stroke prevention in atrial fibrillation,Tablet,20 mg,Oral,VTE treatment,Bleeding,Strong dual inducers of CYP3A4 and P-gp decrease levels increasing stroke risk Risk of serious and fatal bleeding discontinue if active bleeding occurs.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information (Risk of hemorrhage),Prescription
Rivastigmine,Cholinesterase Inhibitor,Alzheimer's disease,Capsule,4.5 mg,Oral,Parkinson's disease dementia,Nausea,Other cholinergic agents can have additive effects Can cause nausea vomiting and weight loss.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Rizatriptan,5-HT1 Agonist,Migraine attacks,Tablet,10 mg,Oral,Dizziness,drowsiness,MAOIs and other 5-HT1 agonists can have additive effects Contraindicated in ischemic heart disease and uncontrolled hypertension.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Ropinirole,Dopamine Agonist,Parkinson's disease,Tablet,1 mg,Oral,restless legs syndrome,Nausea,CYP1A2 inhibitors may increase levels Can cause somnolence and impulse control disorders.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Ropivacaine,Local Anesthetic,Local / regional anesthesia,Solution,2 mg/mL,Injection,Hypotension,nausea,Other local anesthetics or drugs that cause methemoglobinemia can have additive effects Can cause CNS toxicity and methemoglobinemia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Rosiglitazone,Thiazolidinedione,Type 2 diabetes,Tablet,4 mg,Ooral,Weight gain,edema,Strong CYP2C8 inhibitors may increase levels Can cause or exacerbate congestive heart failure and myocardial ischemia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Rosuvastatin,Statin,Hyperlipidemia,Tablet,10 mg,Oral,Headache,myalgia,Not significantly metabolized by CYP450 enzymes fewer interactions Can cause myopathy and rhabdomyolysis.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Rotigotine,Dopamine Agonist,Parkinson's disease,Patch,2 mg/24 hr,Transdermal,restless legs syndrome,Nausea,CYP450 inhibitors are unlikely to significantly affect levels due to transdermal administration Can cause application site reactions and impulse control disorders.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Ruxolitinib,JAK Inhibitor,Myelofibrosis,Tablet,5 mg,Oral,polycythemia vera,Thrombocytopenia,Strong CYP3A4 inhibitors may increase levels Can cause serious infections and myelosuppression.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Sacubitril-Valsartan,ARNI,Heart failure,Tablet,24/26 mg,Oral,Hyperkalemia,hypotension,ACE inhibitors are contraindicated due to increased risk of angioedema Can cause angioedema and hyperkalemia.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information (ARB/ARNI risk),Prescription
Salicylic Acid,Keratolytic,Psoriasis,Solution,6%,Topical,warts,acne,No significant drug interactions For topical use only excessive use can lead to salicylism.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Salmeterol,LABA,Asthma,Inhaler,50 mcg/actuation,Inhalation,COPD,Headache,Other adrenergic drugs can have additive cardiovascular effects Can cause paradoxical bronchospasm and increase the risk of asthma-related death.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Saquinavir,Protease Inhibitor,HIV infection,Tablet,500 mg,Oral,Diarrhea,nausea,Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause GI intolerance and hepatotoxicity.,Refrigerate,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Saxagliptin,DPP-4 Inhibitor,Type 2 diabetes,Tablet,5 mg,Oral,Nasopharyngitis,headache,Strong CYP3A4/5 inhibitors may increase levels May cause hypersensitivity reactions including anaphylaxis.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Scopolamine,Anticholinergic,Motion sickness,Patch,1 mg/72 hr,Transdermal,nausea,Dry mouth,Other anticholinergic drugs can have additive effects Can cause drowsiness and confusion.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Secobarbital,Barbiturate,Insomnia,Capsule,100 mg,Oral,Sedation,dizziness,CNS depressants may enhance sedative effects Can cause respiratory depression and dependence.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Selegiline,MAOI,Parkinson's disease,Tablet,5 mg,Oral,Nausea,dizziness,Other MAOIs and sympathomimetics can cause hypertensive crisis Can cause hypertensive crisis if tyramine-rich foods are consumed in high doses.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Selenium Sulfide,Antifungal / Antiseborrheic,Dandruff,Lotion,2.50%,Topical,seborrheic dermatitis,Hair discoloration,No significant drug interactions For topical use only can cause hair discoloration.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Sertaconazole,Antifungal,Fungal skin infections,Cream,2%,Topical,Skin irritation,burning,No significant drug interactions For topical use only not for ophthalmic use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Sertraline,SSRI,Depression,Tablet,50 mg,Oral,anxiety disorders,Nausea,MAOIs can cause serotonin syndrome and CYP2D6 inhibitors may increase levels May increase risk of bleeding especially with NSAIDs or warfarin.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Sevelamer,Phosphate Binder,Hyperphosphatemia in CKD,Tablet,800 mg,Oral,Nausea,constipation,Can decrease the absorption of many other drugs administer other drugs 1 hour before or 3 hours after Can cause GI side effects and hypocalcemia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Sildenafil,PDE5 Inhibitor,Erectile dysfunction,Tablet,50 mg,Oral,PAH,Headache,Nitrates can cause severe hypotension Can cause priapism and sudden hearing loss.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Silodosin,Alpha-1 Blocker,BPH,Capsule,8 mg,Oral,Retrograde ejaculation,dizziness,Other antihypertensive drugs can have additive effects Can cause retrograde ejaculation and orthostatic hypotension.,Room Temperature,Animal studies have demonstrated safety,No data; not indicated for use in women,Prescription
Simeprevir,Protease Inhibitor,Hepatitis C,Capsule,150 mg,Oral,Rash,photosensitivity,Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause photosensitivity and rash.,Room Temperature,Animal studies have demonstrated safety,No data; use only if benefit justifies risk,Prescription
Simvastatin,Statin,Hyperlipidemia,Tablet,20 mg,Oral,Headache,myalgia,Strong CYP3A4 inhibitors (eg itraconazole) can significantly increase levels and risk of myopathy Can cause myopathy and rhabdomyolysis.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Sirolimus,Immunosuppressant,Organ transplant rejection,Tablet,1 mg,Oral,Stomatitis,hyperlipidemia,Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause hyperlipidemia and immunosuppression.,Refrigerate,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Sitagliptin,DPP-4 Inhibitor,Type 2 diabetes,Tablet,100 mg,Oral,Nasopharyngitis,headache,No significant drug interactions May cause hypersensitivity reactions including anaphylaxis.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Sodium Bicarbonate,Alkalinizing Agent,Metabolic acidosis,Tablet,650 mg,Oral,hyperkalemia,Alkalosis,Can decrease the levels of many drugs by increasing urinary pH Can cause metabolic alkalosis and fluid overload.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Sodium Chloride,Electrolyte,Hyponatremia,Solution,0.90%,Intravenous,fluid replacement,Fluid overload,No significant drug interactions Can cause hypernatremia and fluid overload.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Sodium Oxybate,CNS Depressant,Cataplexy,Solution,500 mg/mL,Oral,excessive daytime sleepiness in narcolepsy,Nausea,CNS depressants including alcohol can cause profound sedation and respiratory depression Can cause sleepwalking and respiratory depression.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Sodium Phenylbutyrate,Urea Cycle Disorder Agent,Urea cycle disorders,Powder,3 g,Oral,Amenorrhea,body odor,No significant drug interactions Can cause body odor and menstrual irregularities.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Sofosbuvir,NS5B Polymerase Inhibitor,Hepatitis C,Tablet,400 mg,Oral,Fatigue,headache,Strong P-gp inducers may decrease levels Generally well-tolerated with fatigue and headache being common.,Room Temperature,Animal studies have demonstrated safety,No data; use with ribavirin is X,Prescription
Solifenacin,Anticholinergic,Overactive bladder,Tablet,5 mg,Oral,Dry mouth,constipation,Strong CYP3A4 inhibitors may increase levels Can cause blurred vision and urinary retention.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Somatropin,Growth Hormone,Growth hormone deficiency,Solution,5 mg,Subcutaneous,Injection site reactions,edema,Glucocorticoids may inhibit the growth-promoting effects Can cause glucose intolerance and slipped capital femoral epiphysis in children.,Refrigerate,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Sorafenib,Kinase Inhibitor,Renal cell carcinoma,Tablet,200 mg,Ooral,hepatocellular carcinoma,Hand-foot skin reaction,Strong CYP3A4 inducers may decrease efficacy Can cause hand-foot skin reaction and hypertension.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Sotalol,Antiarrhythmic (Class III),Ventricular arrhythmias,Tablet,80 mg,Oral,atrial fibrillation,Fatigue,Other drugs that lower heart rate or prolong QT interval can have additive effects Can cause life-threatening ventricular arrhythmias particularly torsades de pointes.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information (Beta-blocker risk),Prescription
Spironolactone,Aldosterone Antagonist,Heart failure,Tablet,25 mg,Oral,hypertension,hyperaldosteronism,ACE inhibitors and ARBs may increase risk of hyperkalemia Can cause hyperkalemia and gynecomastia.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Stavudine,NRTI,HIV infection,Capsule,40 mg,Oral,Peripheral neuropathy,pancreatitis,Other drugs that cause peripheral neuropathy or pancreatitis increase risk Can cause peripheral neuropathy and pancreatitis.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Streptomycin,Aminoglycoside Antibiotic,Tuberculosis,Powder for Injection,1 g,Intramuscular,Ototoxicity,nephrotoxicity,Other nephrotoxic or ototoxic drugs increase risk of toxicity Can cause ototoxicity and nephrotoxicity.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Aminoglycoside risk of ototoxicity),Prescription
Succimer,Heavy Metal Chelator,Lead poisoning,Capsule,100 mg,Oral,Rash,nausea,No significant drug interactions Can cause rash and elevated liver enzymes.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Sucralfate,GI Protectant,Peptic ulcer disease,Tablet,1 g,Oral,Constipation,nausea,Can decrease the absorption of many other drugs administer other drugs 2 hours before or after Can cause constipation.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Sufentanil,Opioid Agonist,Anesthesia,Solution,30 mcg/mL,Intravenous,analgesia,Respiratory depression,CNS depressants including alcohol and benzodiazepines increase sedation risk Life-threatening respiratory depression may occur.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Opioid risk),Prescription
Sulfacetamide,Sulfonamide Antibiotic,Bacterial eye infections,Solution,10%,Ophthalmic,Stinging,burning,No significant drug interactions For ophthalmic use only can cause local irritation.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Sulfadiazine,Sulfonamide Antibiotic,Toxoplasmosis,Tablet,500 mg,Oral,other infections,Nausea,May potentiate the effects of warfarin and sulfonylureas Can cause crystalluria and Stevens-Johnson syndrome.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Kernicterus risk),Prescription
Sulfamethoxazole,Sulfonamide Antibiotic,Bacterial infections (often combined with trimethoprim),Tablet,400 mg,Oral,Nausea,rash,May potentiate the effects of warfarin and sulfonylureas Can cause Stevens-Johnson syndrome and blood dyscrasias.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Kernicterus risk; usually with trimethoprim),Prescription
Sulfasalazine,5-ASA Derivative,Ulcerative colitis,Tablet,500 mg,Oral,rheumatoid arthritis,Nausea,May reduce absorption of digoxin and folic acid Can cause oligospermia and orange-yellow discoloration of urine and skin.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information (Kernicterus risk),Prescription
Sulfinpyrazone,Uricosuric,Gout,Tablet,200 mg,Oral,GI upset,rash,Salicylates antagonize the uricosuric effect Can cause GI upset and blood dyscrasias.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information (Kernicterus risk),Prescription
Sulindac,NSAID,Osteoarthritis,Tablet,200 mg,Oral,rheumatoid arthritis,gout,ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (NSAID risk),Prescription
Sumatriptan,5-HT1 Agonist,Migraine attacks,Tablet,100 mg,Oral,Chest pain,dizziness,Other 5-HT1 agonists and MAOIs can have additive effects Contraindicated in ischemic heart disease and uncontrolled hypertension.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Sunitinib,Kinase Inhibitor,Renal cell carcinoma,Capsule,50 mg,Oral,GIST,Fatigue,Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause hepatotoxicity and left ventricular dysfunction.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Tacrolimus,Calcineurin Inhibitor,Organ transplant rejection,Capsule,1 mg,Oral,immunosuppression,Nephrotoxicity,Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause nephrotoxicity and neurotoxicity.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Tadalafil,PDE5 Inhibitor,Erectile dysfunction,Tablet,10 mg,Oral,BPH,PAH,Nitrates can cause severe hypotension Can cause priapism and back pain.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Tamoxifen,SERM,Breast cancer,Tablet,20 mg,Oral,Hot flashes,vaginal discharge,Strong CYP2D6 inhibitors may decrease levels of active metabolite Increases risk of thromboembolism and endometrial cancer.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Tamsulosin,Alpha-1 Blocker,BPH,Capsule,0.4 mg,Oral,Retrograde ejaculation,dizziness,Other antihypertensive drugs can have additive effects Can cause retrograde ejaculation and orthostatic hypotension.,Room Temperature,Animal studies have demonstrated safety,No data; not indicated for use in women,Prescription
Tapentadol,Opioid Agonist,Pain,Tablet,50 mg,Oral,Constipation,nausea,CNS depressants including alcohol and benzodiazepines increase sedation risk MAOIs can cause serotonin syndrome.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Tazarotene,Retinoid,Plaque psoriasis,Gel,0.10%,Topical,acne,Skin irritation,No significant drug interactions Highly teratogenic females must use effective contraception.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Tedizolid,Oxazolidinone Antibiotic,Bacterial skin infections,Tablet,200 mg,Oral,Nausea,headache,No significant drug interactions Can cause myelosuppression and peripheral neuropathy.,Room Temperature,Animal studies have demonstrated safety,No data; likely C,Prescription
Telavancin,Lipoglycopeptide Antibiotic,Complicated skin infections,Powder for Injection,750 mg,Intravenous,Taste disturbance,nausea,QT-prolonging drugs may have additive effects Can cause nephrotoxicity and fetal toxicity.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Telbivudine,Nucleoside Reverse Transcriptase Inhibitor,Hepatitis B,Tablet,600 mg,Oral,Creatine kinase elevation,fatigue,No significant drug interactions Can cause myopathy and peripheral neuropathy.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Telithromycin,Ketolide Antibiotic,Bacterial infections,Tablet,800 mg,Oral,Diarrhea,nausea,Other QT-prolonging drugs may have additive effects Contraindicated in myasthenia gravis due to risk of life-threatening respiratory failure.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Telmisartan,ARB,Hypertension,Tablet,80 mg,Oral,Hyperkalemia,dizziness,NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Use in pregnancy can cause injury and death to the developing fetus.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information (ARB risk),Prescription
Temazepam,Benzodiazepine,Insomnia,Capsule,15 mg,Oral,Sedation,dizziness,CNS depressants including alcohol and opioids increase sedation risk Abrupt discontinuation can cause withdrawal symptoms.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Temozolomide,Alkylating Agent,Brain tumors,Capsule,5 mg,Oral,Myelosuppression,nausea,Valproic acid may decrease clearance Can cause severe myelosuppression and pneumocystis pneumonia prophylaxis is required.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Temsirolimus,mTOR Inhibitor,Renal cell carcinoma,Solution,25 mg/mL,Intravenous,Rash,asthenia,Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause hyperglycemia and interstitial lung disease.,Refrigerate,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Tenecteplase,Thrombolytic,Acute myocardial infarction,Powder for Injection,50 mg,Intravenous,Bleeding,arrhythmia,Other drugs that affect hemostasis increase bleeding risk Can cause serious and fatal bleeding especially intracranial hemorrhage.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Tenofovir,NRTI,HIV infection,Tablet,300 mg,Oral,Hepatitis B,Nausea,Other nephrotoxic drugs increase risk of renal impairment Can cause renal impairment and decreased bone mineral density.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Terazosin,Alpha-1 Blocker,Hypertension,Capsule,2 mg,Oral,BPH,Dizziness,Other antihypertensive drugs can have additive effects Can cause marked first-dose hypotension and syncope.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Terbinafine,Antifungal,Fungal nail infections,Tablet,250 mg,Oral,other fungal infections,Headache,Strong CYP2D6 inhibitors may increase levels Can cause taste disturbance and hepatotoxicity.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Terbutaline,Beta-2 Agonist,Asthma,Tablet,5 mg,Oral,bronchospasm,tocolysis,Beta-blockers may antagonize the effects Can cause paradoxical bronchospasm and cardiovascular effects.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Terconazole,Antifungal,Vaginal yeast infections,Cream,0.80%,Vaginal,Vaginal burning,itching,No significant drug interactions For vaginal use only can cause vulvovaginal burning.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Teriparatide,Parathyroid Hormone Analog,Osteoporosis,Solution,20 mcg/80 mL,Subcutaneous,Dizziness,leg cramps,No significant drug interactions Can cause orthostatic hypotension and increased risk of osteosarcoma.,Refrigerate,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Testosterone,Androgen,Hypogonadism,Gel,5 mg/24 hr,Topical,Acne,edema,Corticosteroids may increase edema risk and anticoagulants may have increased effects Can cause polycythemia and increased risk of cardiovascular events.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Tetrabenazine,Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor,Huntington's disease chorea,Tablet,25 mg,Oral,Sedation,parkinsonism,Strong CYP2D6 inhibitors may increase levels Can cause depression and suicidal ideation and is contraindicated in untreated depression.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Tetracycline,Tetracycline Antibiotic,Bacterial infections,Capsule,500 mg,Oral,acne,Photosensitivity,Antacids and calcium supplements decrease absorption Can cause photosensitivity and tooth discoloration in children.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Tooth discoloration risk),Prescription
Thalidomide,Immunomodulatory Agent,Multiple myeloma,Capsule,50 mg,Oral,leprosy,Peripheral neuropathy,CNS depressants may enhance sedative effects Is a known human teratogen and requires strict pregnancy prevention program.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information (STEPS program),Prescription
Theophylline,Xanthine Derivative,Asthma,Tablet (ER),300 mg,Oral,COPD,bronchospasm,Many drugs can increase (eg ciprofloxacin) or decrease (eg phenytoin) levels due to CYP1A2 metabolism Has a narrow therapeutic index and can cause seizures and arrhythmias in overdose.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Thioguanine,Antimetabolite,Leukemia,Tablet,40 mg,Oral,Myelosuppression,nausea,Other bone marrow suppressants may have additive effects Can cause severe myelosuppression and hepatotoxicity.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Thioridazine,Typical Antipsychotic,Schizophrenia,Tablet,50 mg,Oral,Extrapyramidal symptoms,sedation,Strong CYP2D6 inhibitors are contraindicated due to risk of QT prolongation Can cause QT prolongation and retinopathy.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Thiotepa,Alkylating Agent,Various cancers,Powder for Injection,15 mg,Intravenous,Myelosuppression,nausea,Other bone marrow suppressants may have additive effects Can cause severe myelosuppression.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Tiagabine,Anticonvulsant,Seizures,Tablet,12 mg,Oral,Dizziness,somnolence,Strong CYP3A4 inducers may decrease efficacy Can cause seizures in patients without epilepsy.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Ticagrelor,P2Y12 Inhibitor,Acute coronary syndrome,Tablet,90 mg,Oral,Bleeding,dyspnea,Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause dyspnea and serious bleeding.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Ticarcillin-Clavulanate,Penicillin Antibiotic + Beta-Lactamase Inhibitor,Bacterial infections,Powder for Injection,3.1 g,Intravenous,Diarrhea,nausea,Probenecid may decrease excretion May cause hypokalemia and bleeding diathesis.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Ticlopidine,Antiplatelet,Stroke prevention (alternative),Tablet,250 mg,Oral,Diarrhea,neutropenia,Proton pump inhibitors may reduce its antiplatelet effect Can cause severe neutropenia and thrombotic thrombocytopenic purpura (TTP).,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Tigecycline,Glycylcycline Antibiotic,Complicated infections,Powder for Injection,50 mg,Intravenous,Nausea,vomiting,Warfarin metabolism may be affected increasing INR Can increase all-cause mortality and is reserved for use when alternatives are not suitable.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Timolol,Beta-Blocker,Glaucoma,Solution,0.50%,Ophthalmic,hypertension,angina,Other drugs that lower heart rate or blood pressure can have additive effects Can cause bronchospasm in patients with asthma.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information (Beta-blocker risk),Prescription
Tinidazole,Nitroimidazole Antibiotic,Amebiasis,Tablet,500 mg,Oral,giardiasis,trichomoniasis,Disulfiram-like reaction can occur with alcohol Can cause peripheral neuropathy and seizures with prolonged use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Tioconazole,Antifungal,Vaginal yeast infections,Ointment,6.50%,Vaginal,Vaginal burning,itching,No significant drug interactions For topical use only not for ophthalmic use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Tiotropium,Anticholinergic,COPD,Capsule for Inhalation,18 mcg,Inhalation,Dry mouth,constipation,Other anticholinergic drugs can have additive effects Can cause paradoxical bronchospasm and narrow-angle glaucoma.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Tipranavir,Protease Inhibitor,HIV infection,Capsule,250 mg,Oral,Diarrhea,nausea,Strong CYP3A4 inducers are contraindicated as they significantly decrease levels Can cause hepatotoxicity and intracranial hemorrhage.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Tirofiban,Glycoprotein IIb/IIIa Inhibitor,Acute coronary syndrome,Solution,50 mcg/mL,Intravenous,Bleeding,dizziness,Other drugs that affect hemostasis increase bleeding risk Can cause severe bleeding and thrombocytopenia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Tizanidine,Alpha-2 Agonist,Muscle spasticity,Tablet,4 mg,Oral,Sedation,dry mouth,Strong CYP1A2 inhibitors (eg fluvoxamine) can significantly increase levels Can cause hypotension and sedation.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Tobramycin,Aminoglycoside Antibiotic,Bacterial infections,Solution,0.30%,Ophthalmic,Nephrotoxicity,ototoxicity,Other nephrotoxic or ototoxic drugs increase risk of toxicity Monitor peak and trough levels to minimize risk of nephrotoxicity and ototoxicity.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Aminoglycoside risk of ototoxicity),Prescription
Tocilizumab,IL-6 Receptor Antagonist,Rheumatoid arthritis,Solution,162 mg/0.9 mL,Subcutaneous,Upper respiratory infection,increased cholesterol,May increase metabolism of CYP450 substrates due to reversal of inflammation-induced suppression Can cause serious infections and gastrointestinal perforations.,Refrigerate,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Tofacitinib,JAK Inhibitor,Rheumatoid arthritis,Tablet,5 mg,Oral,psoriatic arthritis,Upper respiratory infection,Strong CYP3A4 inhibitors may increase levels Can cause serious infections and increased risk of malignancy.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Tolazamide,Sulfonylurea,Type 2 diabetes,Tablet,250 mg,Oral,Hypoglycemia,nausea,Drugs that increase hypoglycemia risk (eg beta-blockers) Can cause severe and prolonged hypoglycemia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information (Sulfonylurea risk of hypoglycemia),Prescription
Tolbutamide,Sulfonylurea,Type 2 diabetes,Tablet,500 mg,Oral,Hypoglycemia,nausea,Drugs that increase hypoglycemia risk (eg beta-blockers) Can cause severe and prolonged hypoglycemia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information (Sulfonylurea risk of hypoglycemia),Prescription
Tolcapone,COMT Inhibitor,Parkinson's disease,Tablet,100 mg,Oral,Diarrhea,urine discoloration,Nonselective MAOIs are contraindicated Can cause hepatotoxicity requiring frequent liver monitoring.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Tolmetin,NSAID,Osteoarthritis,Capsule,400 mg,Oral,rheumatoid arthritis,GI upset,ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (NSAID risk),Prescription
Tolnaftate,Antifungal,Fungal skin infections,Solution,1%,Topical,Skin irritation,pruritus,No significant drug interactions For topical use only not for ophthalmic use.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Tolterodine,Anticholinergic,Overactive bladder,Capsule,2 mg,Oral,Dry mouth,constipation,Strong CYP3A4 inhibitors may increase levels Can cause blurred vision and urinary retention.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Topiramate,Anticonvulsant,Seizures,Tablet,25 mg,Oral,migraine prevention,Weight loss,Can decrease efficacy of oral contraceptives and other drugs by inducing CYP450 enzymes Can cause metabolic acidosis and angle-closure glaucoma.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information (Cleft lip/palate risk),Prescription
Torsemide,Loop Diuretic,Edema (heart failure,Tablet,20 mg,Oral,hepatic,renal),Other ototoxic drugs may increase risk of hearing loss NSAIDs may reduce the diuretic effect Profound diuresis and electrolyte depletion can occur.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Tramadol,Opioid Agonist,Pain,Tablet,50 mg,Oral,Constipation,nausea,CNS depressants including alcohol and benzodiazepines increase sedation risk MAOIs and other serotonergic drugs can cause serotonin syndrome.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Trandolapril,ACE Inhibitor,Hypertension,Tablet,2 mg,Oral,heart failure,Cough,NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Risk of angioedema can occur at any time discontinue immediately.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information (ACE Inhibitor risk),Prescription
Tranexamic Acid,Antifibrinolytic,Heavy menstrual bleeding,Tablet,650 mg,Oral,bleeding prevention,Nausea,No significant drug interactions Can cause thrombosis and visual disturbances.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Trazodone,Serotonin Antagonist and Reuptake Inhibitor (SARI),Depression,Tablet,50 mg,Oral,insomnia,Sedation,CNS depressants may enhance sedative effects Can cause priapism a medical emergency.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Treprostinil,Prostacyclin Analog,Pulmonary arterial hypertension (PAH),Solution,1 mg/mL,Subcutaneous,Headache,diarrhea,Other vasodilators or antihypertensive drugs can have additive effects Can cause infusion site pain and reaction.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Tretinoin,Retinoid,Acne vulgaris,Cream,0.05%,Topical,Skin dryness,erythema,No significant drug interactions Highly teratogenic and can cause severe skin irritation.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Triamcinolone,Corticosteroid,Inflammatory conditions,Ointment,0.10%,Topical,Hyperglycemia,fluid retention,CYP3A4 inducers (eg phenytoin) may decrease efficacy and inhibitors may increase effects Can cause hyperglycemia and adrenal suppression with prolonged use.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Triamterene,Potassium-Sparing Diuretic,Hypertension,Capsule,50 mg,Oral,edema,Hyperkalemia,ACE inhibitors and ARBs may increase risk of hyperkalemia Can cause hyperkalemia and kidney stones.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Triamterene-Hydrochlorothiazide,Potassium-Sparing Diuretic + Thiazide Diuretic,Hypertension,Capsule,37.5/25 mg,Oral,Hyperkalemia,dizziness,ACE inhibitors and ARBs may increase risk of hyperkalemia and other drugs that lower potassium may have additive effects Can cause electrolyte imbalances including hyperkalemia and hypokalemia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information (ACE Inhibitor/Thiazide risk),Prescription
Triazolam,Benzodiazepine,Insomnia,Tablet,0.25 mg,Oral,Sedation,dizziness,Strong CYP3A4 inhibitors are contraindicated due to risk of profound sedation Can cause anterograde amnesia and severe sedation.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Trifluoperazine,Typical Antipsychotic,Psychotic disorders,Tablet,5 mg,Oral,Extrapyramidal symptoms,sedation,CNS depressants may enhance sedative effects Can cause extrapyramidal symptoms and neuroleptic malignant syndrome.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Trimethoprim,Antibiotic,UTIs (often combined with sulfamethoxazole),Tablet,100 mg,Oral,Nausea,rash,May increase levels of phenytoin and digoxin Can cause hyperkalemia and blood dyscrasias.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information,Prescription
Trimipramine,Tricyclic Antidepressant,Depression,Capsule,25 mg,Oral,Dry mouth,sedation,MAOIs can cause serotonin syndrome and hyperpyrexia Strong anticholinergic effects may occur with other drugs Increased risk of suicide in children and young adults.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Triprolidine,Antihistamine,Allergic rhinitis,Syrup,2.5 mg/5 mL,Oral,Sedation,dry mouth,CNS depressants may enhance sedative effects May cause marked drowsiness and impair mental and physical abilities.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Triptorelin,GnRH Agonist,Prostate cancer,Powder for Injection,3.75 mg,Intramuscular,endometriosis,Hot flashes,No significant drug interactions Causes an initial increase in testosterone levels which may worsen symptoms in prostate cancer patients.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Tropicamide,Anticholinergic,Ocular cycloplegia,Solution,1%,Ophthalmic,mydriasis,Blurred vision,Other anticholinergic drugs can have additive effects Contraindicated in patients with angle-closure glaucoma.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Trospium,Anticholinergic,Overactive bladder,Tablet,20 mg,Oral,Dry mouth,constipation,Other anticholinergic drugs can have additive effects Can cause blurred vision and urinary retention.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Umeclidinium,Anticholinergic,COPD,Inhaler,62.5 mcg/actuation,Inhalation,Dry mouth,constipation,Other anticholinergic drugs can have additive effects Can cause paradoxical bronchospasm and narrow-angle glaucoma.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Undecylenic Acid,Antifungal,Fungal skin infections (e.g.,Ointment,25%,Topical,athlete's foot),Skin irritation,No significant drug interactions For topical use only not for ophthalmic use.,Room Temperature,Animal studies have demonstrated safety,No data,No prescription required
Urea,Keratolytic,Dry skin,Cream,40%,Topical,xerosis,hyperkeratotic conditions,No significant drug interactions For topical use only can cause mild irritation.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,No prescription required
Urokinase,Thrombolytic,Pulmonary embolism,000 unit,250,Powder for Injection,Acute myocardial infarction,Bleeding,Other drugs that affect hemostasis increase bleeding risk Can cause serious and fatal bleeding especially intracranial hemorrhage.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Intravenous
Ursodiol,Gallstone Dissolution Agent,Gallstones,Capsule,300 mg,Oral,primary biliary cholangitis,Diarrhea,Aluminum-based antacids and cholestyramine may reduce absorption Generally well-tolerated with diarrhea being the most common side effect.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Valacyclovir,Antiviral,Herpes simplex virus (HSV) infections,Tablet,500 mg,Oral,Varicella zoster virus (VZV) infections,Headache,Probenecid may decrease acyclovir clearance increasing its levels Maintain adequate hydration to prevent nephrotoxicity especially in elderly or dehydrated patients.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Valganciclovir,Antiviral,Cytomegalovirus (CMV) retinitis,Tablet,450 mg,Oral,Myelosuppression,diarrhea,Probenecid may decrease ganciclovir excretion Can cause severe myelosuppression and mutagenesis.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Valproic Acid,Anticonvulsant,Seizures,Capsule,250 mg,Oral,bipolar disorder,migraine prevention,CYP450 enzyme inducers may decrease levels Can cause severe hepatotoxicity and teratogenic effects including neural tube defects.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Neural tube defect risk),Prescription
Valsartan,ARB,Hypertension,Tablet,80 mg,Oral,heart failure,post-MI,NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Use in pregnancy can cause injury and death to the developing fetus.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information (ARB risk),Prescription
Vancomycin,Glycopeptide Antibiotic,Serious bacterial infections (e.g.,Capsule,125 mg,Oral,MRSA),Red man syndrome,Other nephrotoxic drugs increase risk of toxicity Monitor levels to minimize risk of nephrotoxicity and ototoxicity (red man syndrome).,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Vandetanib,Kinase Inhibitor,Thyroid cancer,Tablet,100 mg,Oral,Diarrhea,rash,Strong CYP3A4 inhibitors may increase levels Can cause QT prolongation torsades de pointes and sudden death.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Vardenafil,PDE5 Inhibitor,Erectile dysfunction,Tablet,10 mg,Oral,Headache,flushing,Nitrates can cause severe hypotension Can cause priapism and sudden hearing loss.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Varenicline,Nicotinic Acetylcholine Receptor Partial Agonist,Smoking cessation,Tablet,0.5 mg,Oral,Nausea,abnormal dreams,No significant drug interactions Can cause serious neuropsychiatric events including depression and suicidal thoughts.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Varicella Vaccine,Vaccine,Prevention of varicella (chickenpox),Powder for Injection,1350 PFU/0.5 mL,Subcutaneous,Injection site reactions,fever,Immunosuppressive drugs may diminish the immune response Contraindicated in immunosuppression and pregnancy.,Frozen,Contraindicated (not allowed),Contraindicated; live vaccine,Prescription
Vasopressin,Posterior Pituitary Hormone,Diabetes insipidus,Solution,20 units/mL,Intravenous,vasodilatory shock,Abdominal cramps,Other drugs that can cause water intoxication may have additive effects Can cause hyponatremia and tissue necrosis with extravasation.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Vemurafenib,Kinase Inhibitor,Melanoma (BRAF V600E mutation),Tablet,240 mg,Oral,Arthralgia,rash,Strong CYP3A4 inducers may decrease efficacy Can promote the growth of certain skin cancers and cause QT prolongation.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Venlafaxine,SNRI,Depression,Capsule (ER),75 mg,Oral,anxiety disorders,Nausea,MAOIs can cause serotonin syndrome Can increase blood pressure and cause withdrawal symptoms upon discontinuation.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription
Verapamil,Non-Dihydropyridine CCB,Hypertension,Tablet (SR),120 mg,Oral,angina,atrial arrhythmias,CYP3A4 inhibitors can increase levels and inducers can decrease levels Can cause bradycardia and heart failure.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Vigabatrin,Anticonvulsant,Seizures,Tablet,500 mg,Oral,infantile spasms,Sedation,Other drugs that cause visual field defects may have additive effects Can cause permanent concentric visual field constriction.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Vilazodone,Serotonin Partial Agonist and Reuptake Inhibitor (SPARI),Depression,Tablet,20 mg,Oral,Diarrhea,nausea,MAOIs can cause serotonin syndrome Can cause diarrhea and insomnia.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Vinblastine,Vinca Alkaloid,Hodgkin's lymphoma,Solution,1 mg/mL,Intravenous,other cancers,Myelosuppression,Strong CYP3A4 inhibitors may increase levels Can cause severe myelosuppression and extravasation injury.,Refrigerate Protect from light,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Vincristine,Vinca Alkaloid,Leukemias,Solution,1 mg/mL,Intravenous,lymphomas,other cancers,Strong CYP3A4 inhibitors may increase levels Can cause severe peripheral neuropathy and extravasation injury.,Refrigerate Protect from light,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Vinorelbine,Vinca Alkaloid,Non-small cell lung cancer,Solution,10 mg/mL,Intravenous,breast cancer,Myelosuppression,Strong CYP3A4 inhibitors may increase levels Can cause severe myelosuppression and extravasation injury.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Voriconazole,Azole Antifungal,Invasive fungal infections,Tablet,200 mg,Oral,Visual disturbances,rash,Inhibits CYP3A4 increasing levels of many drugs (eg statins) Can cause visual disturbances hepatotoxicity and photosensitivity.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Vortioxetine,Multimodal Antidepressant,Depression,Tablet,10 mg,Oral,Nausea,constipation,MAOIs can cause serotonin syndrome Can cause nausea and increased risk of bleeding.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Warfarin,Anticoagulant (Vitamin K Antagonist),Thromboembolism prevention/treatment,Tablet,5 mg,Oral,Bleeding,skin necrosis,A vast number of drugs can increase or decrease INR through various mechanisms Has a narrow therapeutic index and requires frequent INR monitoring to prevent bleeding or clotting.,Room Temperature,Positive evidence of fetus risks but benefits may outweigh risks in some cases,FDA Prescribing Information (Warfarin embryopathy risk),Prescription
Zafirlukast,Leukotriene Receptor Antagonist,Asthma,Tablet,20 mg,Oral,Headache,nausea,Warfarin metabolism is inhibited increasing INR Can cause hepatic failure and Churg-Strauss syndrome.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Zaleplon,Non-Benzodiazepine Hypnotic,Insomnia,Capsule,10 mg,Oral,Dizziness,somnolence,CNS depressants including alcohol increase sedation risk Can cause complex sleep behaviors like sleep-driving.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Zanamivir,Neuraminidase Inhibitor,Influenza,Powder for Inhalation,5 mg/Blister,Inhalation,Nausea,diarrhea,No significant drug interactions Can cause bronchospasm in patients with underlying airways disease.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Zidovudine,NRTI,HIV infection,Tablet,300 mg,Oral,Anemia,neutropenia,Other bone marrow suppressants may have additive effects Can cause severe myelosuppression and myopathy.,Room Temperature,Human studies have proved safety,FDA Prescribing Information,Prescription
Zileuton,5-Lipoxygenase Inhibitor,Asthma,Tablet,600 mg,Oral,Headache,nausea,Theophylline and warfarin levels may be increased Can cause hepatotoxicity and requires monitoring of liver enzymes.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Ziprasidone,Atypical Antipsychotic,Schizophrenia,Capsule,40 mg,Oral,bipolar disorder,Somnolence,Other drugs that prolong the QT interval are contraindicated Can cause QT prolongation and rash.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Zoledronic Acid,Bisphosphonate,Hypercalcemia of malignancy,Solution,5 mg/100 mL,Intravenous,bone metastases,Flu-like symptoms,Nephrotoxic drugs may increase risk of renal impairment Can cause renal impairment and osteonecrosis of the jaw.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Zolmitriptan,5-HT1 Agonist,Migraine attacks,Tablet,2.5 mg,Oral,Dizziness,somnolence,Other 5-HT1 agonists and MAOIs can have additive effects Contraindicated in ischemic heart disease and uncontrolled hypertension.,Room Temperature,Contraindicated (not allowed),FDA Prescribing Information,Prescription
Zolpidem,Non-Benzodiazepine Hypnotic,Insomnia,Tablet,10 mg,Oral,Dizziness,somnolence,CNS depressants including alcohol increase sedation risk Can cause complex sleep behaviors like sleep-driving.,Room Temperature,Animal studies have demonstrated safety,FDA Prescribing Information,Prescription
Zonisamide,Anticonvulsant,Seizures,Capsule,100 mg,Oral,Somnolence,dizziness,Strong CYP3A4 inducers may decrease levels Can cause oligohydrosis and hyperthermia in children and metabolic acidosis.,Room Temperature,Animal studies have proved adverse effects but may be safe for humans,FDA Prescribing Information,Prescription